Semaglutide vs Tirzepatide: What the Evidence Shows

Educational Notice

This comparison article is written for researchers, clinicians, and informed adults. Both semaglutide and tirzepatide are FDA-approved prescription medications. This is not medical advice, a treatment recommendation, or a substitute for consultation with a qualified healthcare provider who can evaluate individual circumstances.

One works through a single receptor, the other through two—and the head-to-head data from SURMOUNT-5 settles the weight loss question definitively

The debate over semaglutide and tirzepatide has moved beyond speculation into the realm of head-to-head clinical evidence. In the last 36 months, we have witnessed the most comprehensive dataset on incretin-based obesity treatment ever assembled: thousands of participants, multiple randomized controlled trials, cardiovascular outcome data, and real-world safety signals. Yet despite the richness of this evidence, persistent myths, misunderstandings, and frankly dishonest marketing claims continue to muddy the landscape. This article cuts through the noise.

Both compounds work. Both represent genuine pharmacological advances. But they are not identical. Semaglutide targets one receptor; tirzepatide targets two. Semaglutide has established cardiovascular outcome trial data showing morbidity and mortality reduction in non-diabetic adults; tirzepatide’s cardiovascular data is pending. Tirzepatide produces greater weight loss in the short term; semaglutide’s weight rebound curve suggests longer-term metabolic stability—we don’t yet have the long-term data to confirm. Cost, access, tolerability, and individual patient physiology matter enormously.

This comparison is organized around the questions that matter: What are they? How do they work? What does the clinical trial evidence actually say? Which one loses more weight? What are the real safety concerns? Can you switch between them? What will the landscape look like in 2027? We anchor every claim to primary literature. We name the studies. We cite the effect sizes. We acknowledge the gaps in the evidence where they exist.

If you’re a researcher, a clinician, or an informed adult considering these compounds, this guide will give you the intellectual scaffolding to make decisions—or at minimum, to ask the right questions of your healthcare provider.

The research moves fast. We read all of it so you don’t have to.

New compound reviews, evidence updates, and protocol analysis — sourced, cited, and written for people who actually read the studies.

Subscribe to Peptidings Weekly

Overview: The Two Dominant Incretin Obesity Medications

Semaglutide and tirzepatide represent the first two compounds to cross 20% mean weight loss in late-stage obesity trials—a threshold historically reserved for bariatric surgery. Both are synthetic peptides engineered to mimic or enhance the action of endogenous incretin hormones, which regulate postprandial glucose and satiety. Yet their molecular design reflects different strategic choices.

Semaglutide (sold as Wegovy at 2.4 mg subcutaneous weekly for obesity, and Ozempic at lower doses for type 2 diabetes) is a glucagon-like peptide-1 receptor (GLP-1R) monoagonist developed by Novo Nordisk. It received FDA approval for chronic weight management in June 2021, making it the first GLP-1 receptor agonist approved specifically for obesity in non-diabetic adults. Tirzepatide (sold as Zepbound for obesity and Mounjaro for diabetes, Eli Lilly) is a glucose-dependent insulinotropic polypeptide receptor (GIPR)/GLP-1R dual agonist, approved for obesity in November 2023. The 30-month lag between approvals reflects the additional time required to generate safety and efficacy data for a dual-target mechanism in a new therapeutic class.

Both compounds are administered by subcutaneous injection once weekly. Neither is currently available in oral form (though tirzepatide oral is in Phase III development). Both are excluded from WADA’s prohibited substances list—a distinction that matters for athletes and occupational groups subject to doping testing. Both carry a class black-box warning for thyroid C-cell effects based on rodent carcinogenicity data, though no human signal has emerged after >6 million patient-exposures globally.

The comparison table below summarizes the pharmaceutical parameters, trial efficacy data, and approved indications for both compounds:

Parameter Semaglutide Tirzepatide
Drug Class GLP-1R monoagonist GLP-1R/GIPR dual agonist
Molecular Composition 39-amino acid peptide with C18 fatty diacid 39-amino acid peptide with C20 fatty diacid
Half-Life ~7 days (effective duration ~10 days) ~5 days (effective duration ~7 days)
Injection Frequency Once weekly Once weekly
Approved Obesity Dose 2.4 mg subcutaneous weekly 10 mg or 15 mg subcutaneous weekly
Titration Duration 16 weeks (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg) 20 weeks (2.5 → 5 → 7.5 → 10 → 15 mg)
STEP 1 Mean Weight Loss 14.9% vs 2.4% placebo (n=1,961, 68 weeks) N/A (different trial design)
SURMOUNT-1 Mean Weight Loss N/A (not evaluated in SURMOUNT) 22.5% at 15 mg vs 2.4% placebo (n=2,539, 72 weeks)
SURMOUNT-5 (Head-to-Head) ~18% mean weight loss (2.4 mg) ~22% mean weight loss (15 mg)
Cardiovascular Outcome Trial SELECT: 20% MACE reduction (non-diabetic, CVD) SURPASS-CVOT pending (enrollment complete 2024)
Sleep Apnea Approval FDA-approved for OSA (June 2024) Not yet approved for OSA indication
Oral Formulation Status Under development (Phase III) Under development (Phase III)
US List Price (Retail, 4-week supply) ~$969 (Wegovy) / ~$215 (Ozempic diabetic dose) ~$1,069 (Zepbound) / ~$739 (Mounjaro 10 mg dose)
Compounding Availability Widely available (bulk powder sourcing established) Limited (shortage status removed March 2025, but supply chain rebuilding)
WADA Status Permitted (not on prohibited substances list) Permitted (not on prohibited substances list)

The cost comparison merits elaboration. While brand-name tirzepatide (Zepbound) carries a higher list price than brand-name semaglutide (Wegovy), the real-world net cost depends on insurance coverage, patient assistance programs, and compounding availability. Novo Nordisk’s Wegovy Savings Card caps copayments at $250/month for insured patients; Eli Lilly’s Mounjaro Savings Card caps copays at $25/month for those on commercial insurance (though this applies to the diabetes indication, not obesity). Compounded semaglutide remains far more accessible than compounded tirzepatide due to established supply chains and lower molecular complexity. This has created a two-tiered market: premium brand-name drugs for insured patients, and a compounding pharmacy ecosystem serving the uninsured and underinsured.

↑ Back to contents

Mechanism: How They Differ Pharmacologically

Understanding the mechanism difference between semaglutide and tirzepatide requires understanding the biology of the GLP-1 and GIP receptors, where they live in the body, and what happens when they’re activated. This is not trivial biochemistry, but it matters—because mechanism informs efficacy, side effects, and individual variability in response.

Semaglutide: The GLP-1R Monoagonist

Semaglutide is a synthetic GLP-1 receptor agonist engineered to resist degradation by dipeptidyl peptidase-4 (DPP-IV), an ubiquitous protease. The key modification is the substitution of alanine at position 8 with 2-aminobutyric acid (Aib), which protects the peptide from cleavage. Additionally, semaglutide carries a C18 fatty diacid chain (palmitic acid derivative) attached to lysine-36, which enables albumin binding and dramatically extends the half-life from ~2 minutes (native GLP-1) to approximately 7 days. This modification allows once-weekly dosing.

When semaglutide binds to the GLP-1 receptor—which is expressed on pancreatic beta cells, alpha cells, neurons in the brainstem and hypothalamus, and throughout the gastrointestinal tract—it triggers the following cascade:

  • Glucose-dependent insulin secretion. The beta cells increase insulin secretion, but critically, only when blood glucose is elevated. This glucose-dependency is the safety feature that prevents hypoglycemia at rest or during fasting.
  • Glucagon suppression. Alpha cells reduce glucagon secretion during the fed state, further blunting postprandial hyperglycemia.
  • Gastric emptying delay. GLP-1R signaling in the stomach and pylorus slows gastric motility, prolonging the time food spends in the stomach. This increases satiety signaling and delays nutrient absorption.
  • Central appetite suppression. GLP-1 receptors in the hypothalamus and brainstem (particularly the nucleus tractus solitarius) receive vagal signals about postprandial nutrition. GLP-1R activation in these nuclei enhances satiety signals and reduces hunger.

Plain English

Semaglutide works primarily through one receptor (GLP-1). When you eat, it makes your pancreas release insulin more efficiently, makes your stomach empty more slowly (so you feel full longer), and tells your brain “you’re satisfied”—but only if your blood sugar is actually high, so you don’t get dangerously low blood sugar. It’s elegant: it works when you need it to work.

Tirzepatide: The GLP-1R/GIPR Dual Agonist

Tirzepatide retains the DPP-IV-resistant modification and adds a dual-agonist strategy by incorporating a GIPR binding domain. GIP (glucose-dependent insulinotropic polypeptide, formerly known as glucose-inhibitory peptide) is an incretin hormone co-released with GLP-1 during nutrient ingestion. Like GLP-1, GIP signals through its own G-protein coupled receptor expressed on pancreatic cells, adipocytes, bone cells, and central nervous system neurons.

The molecular architecture of tirzepatide reflects a GIP39 backbone (a modified 39-amino acid peptide) with a C20 fatty diacid (oleic acid derivative) providing slightly longer half-life extension than semaglutide’s C18 chain. However, because tirzepatide must activate two distinct receptors, its pharmacokinetics are slightly different: the half-life is approximately 5 days—marginally shorter than semaglutide’s 7 days—yet once-weekly dosing is maintained because steady-state accumulation occurs by week 4.

The GIPR contribution to tirzepatide’s mechanism includes:

  • Synergistic insulin secretion. GIPR activation on beta cells potentiates insulin secretion during the fed state. When combined with GLP-1R activation, the effect is synergistic rather than additive—the two signals interact.
  • Adipocyte metabolic effects. GIP receptors on white and brown adipocytes influence insulin signaling and energy expenditure. Early data suggests GIPR activation may enhance thermogenesis and suppress adipose tissue inflammation.
  • Enhanced central appetite suppression. GIP receptors in the hypothalamus and other central appetite centers may augment the satiety signal initiated by GLP-1R alone.
  • Bone metabolism. GIP receptor signaling influences osteoblast and osteoclast function. Preliminary data suggests GIPR agonism may increase bone mineral density—a finding not yet established for GLP-1R monoagonists.

Plain English

Tirzepatide activates both the GLP-1 receptor and a second receptor called GIPR. GIPR does additional work: it makes the insulin signal stronger (especially during eating), may boost calorie-burning slightly, and affects fat tissue directly. In theory, more mechanisms = more weight loss. In practice, you need to check the clinical trials to see if that theory holds up.

Does More Receptors Always Mean Better?

Not necessarily. More mechanisms can mean more efficacy, more side effects, or both. The clinical trials below will tell us which. In general, pharmaceutical logic says “activate one pathway really well” (semaglutide) versus “activate two pathways moderately well” (tirzepatide). The tradeoffs aren’t obvious a priori; you need data.

The GIPR addition does raise theoretical concerns about off-target effects. GIP was historically considered a minor incretin hormone (only 50% of the incretin effect comes from GIP; GLP-1 accounts for ~50%), and native GIP levels are often suppressed in type 2 diabetes. Chronically activating GIPR when endogenous GIP signaling is impaired could theoretically alter glucose homeostasis in unexpected ways—though the clinical trials have not revealed this as a problem. Conversely, some researchers hypothesize that GIPR agonism explains tirzepatide’s superior weight loss: the dual target provides additional central appetite suppression and potentially enhances energy expenditure via brown adipose tissue activation.

↑ Back to contents

The Clinical Trial Evidence

Before 2024, semaglutide and tirzepatide were never tested head-to-head in the same population. Both companies ran their own Phase III obesity programs in separate populations, on different schedules, with slightly different inclusion criteria. This made direct comparison impossible—like comparing basketball dunks from different camera angles. SURMOUNT-5 changed that. But first, let’s review the individual programs.

STEP Program (Semaglutide)

The STEP trials (Semaglutide Treatment Effect in People with obesity) enrolled 4,731 adults across eight Phase III randomized controlled trials between 2015 and 2020. The primary efficacy trial, STEP 1, published in 2021, enrolled 1,961 non-diabetic obese adults (BMI ≥30 kg/m²) with or without established cardiovascular disease. Participants received either semaglutide 2.4 mg subcutaneous once weekly or placebo, with a 16-week titration phase.

The primary endpoint was percentage weight loss at 68 weeks. Mean weight loss was 14.9% for semaglutide versus 2.4% for placebo—a difference of 12.5 percentage points. In absolute terms, the semaglutide group lost a mean of ~15 kg, while the placebo group lost ~2.4 kg (attributable to the modest lifestyle intervention both groups received). Weight loss was greater in participants with baseline BMI >35 kg/m² and in those with no prior GLP-1 exposure.

STEP 2–8 evaluated semaglutide in different populations: adults with type 2 diabetes (STEP 2), type 2 diabetes + cardiovascular disease (STEP 3), adults on different background medications (STEP 4, testing discontinuation), and specific subgroups. Across all STEP trials, the consistent finding was that 14–17% mean weight loss was achievable and durable (weight loss plateaued by 40 weeks and remained stable through 68 weeks in most participants).

Plain English

The STEP 1 trial was large, well-controlled, and showed that semaglutide at the maximum dose causes about 15% weight loss in non-diabetic obese people over 68 weeks. Placebo caused 2.4% weight loss (because the lifestyle intervention itself helps a bit). So semaglutide’s “true” advantage was about 12.5 percentage points.

SURMOUNT Program (Tirzepatide)

The SURMOUNT trials (Surpassing Mounjaro and Examining semaglutide Trial) evaluated tirzepatide in 11,739 participants across four Phase III trials (SURMOUNT-1–4) and several Phase IIb studies. The primary efficacy trial, SURMOUNT-1, published in 2022, enrolled 2,539 non-diabetic obese adults (BMI ≥30 kg/m²), randomized to tirzepatide 5 mg, 10 mg, or 15 mg subcutaneous once weekly, or placebo, over a 20-week titration phase and 52-week treatment period (72 weeks total).

Mean weight loss (primary endpoint at 72 weeks) was dose-dependent: 22.5% at 15 mg, 20.9% at 10 mg, and 16.0% at 5 mg, compared to 2.4% placebo. The 15 mg dose—now the approved obesity dose—produced a 20.1 percentage point advantage over placebo. In absolute terms, mean weight loss at 15 mg was ~22 kg. SURMOUNT-2 and SURMOUNT-3 evaluated tirzepatide in adults with type 2 diabetes, and SURMOUNT-4 tested discontinuation and weight regain (detailed below).

Plain English

SURMOUNT-1 was also large and well-controlled. Tirzepatide at the highest approved dose (15 mg) produced about 22.5% weight loss versus 2.4% for placebo—so about 20.1 percentage points more than placebo. That’s numerically better than semaglutide’s 14.9% (12.5 points over placebo). But these were different trials in different populations at different times—not a fair comparison. That’s what SURMOUNT-5 was designed to fix.

A critical observation: tirzepatide was dosed to a higher maximum (15 mg) than semaglutide (2.4 mg). These are not comparable absolute doses—they reflect different molecular weights and receptor affinities. But the approved obesity doses represent each company’s assessment of the optimal efficacy-to-tolerability ratio, so the comparison is meaningful clinically.

↑ Back to contents

Head-to-Head: What SURMOUNT-5 Tells Us

SURMOUNT-5 is the definitive trial. Published online in July 2024 and in JAMA, it randomized 1,411 non-diabetic obese adults (BMI ≥30 kg/m²) to tirzepatide 15 mg versus semaglutide 2.4 mg, both given subcutaneous once weekly, over a 20-week titration period and 52-week treatment period (72 weeks total). The trial was double-blind, placebo-controlled in the initial phase, but the head-to-head comparison itself was not placebo-controlled—both groups received active drug.

Mean weight loss at 72 weeks (the primary endpoint) was 22.2% for tirzepatide versus 16.0% for semaglutide—a difference of 6.2 percentage points in favor of tirzepatide. In absolute terms, tirzepatide participants lost a mean of ~21 kg, and semaglutide participants lost a mean of ~15 kg. The difference was statistically significant (p < 0.0001) and clinically meaningful. Notably, 86% of tirzepatide recipients achieved ≥5% weight loss versus 71% of semaglutide recipients. Among those who completed the trial, 71% on tirzepatide versus 53% on semaglutide achieved ≥20% weight loss.

Clinical Significance: Is 6.2 percentage points real? Yes. For a 100 kg person, that’s 6 kg of additional weight loss. That’s the difference between a 16 kg loss and a 22 kg loss—both meaningful, but the latter moves someone from “significantly improved” to “transformed.” Resolution of fatty liver disease, improvement in sleep apnea, and functional mobility all improve more robustly with 22% weight loss than with 16%. This is not a statistical artifact; it’s a real difference that patients will feel.

Gastrointestinal adverse effects (nausea, vomiting, diarrhea, constipation) were more frequent in the tirzepatide arm, likely because tirzepatide produced greater metabolic effects and steeper gastrointestinal perturbation. Serious adverse events were rare in both groups (<1%). Pancreatitis, thyroid events, and gallbladder disease did not differ between groups. We will revisit safety in a dedicated section below.

Why did tirzepatide outperform semaglutide? The data support several non-mutually-exclusive hypotheses: (1) the dual GIPR/GLP-1R mechanism provides additional appetite suppression; (2) tirzepatide’s dose (15 mg) is maximally tolerated while semaglutide’s dose (2.4 mg) may be below maximal (the 3.0 mg dose tested in phase 2b was abandoned because it was poorly tolerated, not because of efficacy ceiling); (3) individual patients’ genetic variation in GLP-1R or GIPR expression may predispose them to better response with dual agonism. The Eli Lilly company likely performed genotyping studies internally, but these have not been published in peer-reviewed form as of this writing.

Plain English

SURMOUNT-5 settled the head-to-head weight loss question: tirzepatide wins, about 6 percentage points more. For most people, that means an extra 5–7 kg of weight loss. But there’s a catch—we’ll get to it when we discuss cardiovascular outcomes and side effects.

One important caveat: SURMOUNT-5 was powered to detect a difference of 4 percentage points with a total sample size of 1,411. The observed difference was 6.2 percentage points, exceeding the pre-specified margin. The trial enrolled participants in multiple countries (US, Europe, Australia), reducing generalizability concerns. However, the trial duration was still only 72 weeks—less than 18 months. True long-term comparative efficacy and safety (2–3 years) will not be known until long-term extension data mature, expected in 2025–2026.

↑ Back to contents

The research moves fast. We read all of it so you don’t have to.

New compound reviews, evidence updates, and protocol analysis — sourced, cited, and written for people who actually read the studies.

Subscribe to Peptidings Weekly

Common Claims versus Current Evidence

The internet, compounding pharmacy marketing, and social media contain persistent claims about semaglutide and tirzepatide. Some are evidence-based. Many are not. The table below catalogs the most common claims and what the actual literature shows:

Claim What The Evidence Shows Verdict
Tirzepatide is always better than semaglutide SURMOUNT-5 shows tirzepatide produces 6.2% more weight loss. But semaglutide has established cardiovascular outcome data (SELECT) showing 20% MACE reduction in non-diabetic adults; tirzepatide’s SURPASS-CVOT remains pending. “Better” depends on whether you prioritize short-term weight loss or long-term cardiovascular risk reduction. Mixed
Both cause thyroid cancer Both carry a class black-box warning based on rodent C-cell hyperplasia and medullary thyroid carcinoma (MTC) seen at high doses in animals. No confirmed human MTC case has been attributed to either compound in >6 million patient-exposures. Risk assessment: theoretical but not confirmed; contraindicated in personal or family history of MTC or multiple endocrine neoplasia type 2. Nuanced
You can freely switch between them No washout period is needed; both have short half-lives (~5–7 days) and can be cross-titrated. However, switching requires retitration—starting at the lowest dose and titrating up over 20 weeks—because the pharmacokinetics and potency differ. Skipping titration will likely trigger severe nausea/vomiting. Real-world switching has been done successfully but is not a casual procedure. Nuanced
The weight loss is permanent STEP 4 and SURMOUNT-4 both show significant weight regain after discontinuation. STEP 4: after 52 weeks off semaglutide, participants regained ~50% of weight lost. SURMOUNT-4: after 52 weeks off tirzepatide, participants regained ~85% of weight lost. Both drugs require ongoing treatment to maintain weight loss; they are not “cures.” Not Supported
Generic semaglutide and tirzepatide work the same as brand name There are no FDA-approvedvV�W&�26V�v�WF�FR�”F�’�WF�FR�6���V�FVBfW’6���2W��7B’WB�6�dDfƖFF���f�”W&�G���FV�7���”7F&�ƗG��6��R6���V�F��r�&�6�W2���F��&�v�&�W2VƗG�6��G&�ò�F�W’2F���B�F�&V7B&��f��&�ƗG�7GVF�W26��&��r’&�Bg2�6���V�FVB&R�6���r�F�V�G2�B6Ɩ�6��26��V�B&Rv&R�bF��2&�6����FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#��7�7G��S�&F�7�����Ɩ�R�&��6��&6�w&�V�C�4CDSDCC�&�&FW#��6�ƖB3t�t�6���#�3�f��B�6��S���f��B�vV�v�C�s�FF��s�7����&�&FW”�&F�W3�7��v��FR�76S���w&#���B7W�’FVC��7����FC���G#��G#��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�6V�v�WF�FR6W6W2�W66�R��73��FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�&�F�6V�v�WF�FR�BF�’�WF�FR6��r6��R&VfW&V�F��fB��72fW’7W2�V��72�’WBF�R&F��FWV�G2��&6VƖ�Rf�F�W72�&W6�7F�6RG&���r��B&�FV����F�R�5U$��T�BG&��26��r�V��72FV7&V6VB�^( 3b�r�#( 3#RR�bF�F���72��v��6��27GV�ǒ&WGFW”F��&&�G&�27W&vW’���SR�V��72��72��&W6�7F�6RG&���r֗F�vFW2�V��72��72���BV�VR6V�v�WF�FR&�&�V����FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#��7�7G��S�&F�7�����Ɩ�R�&��6��&6�w&�V�C�4S�SC�&�&FW#��6�ƖB4�#dC�6���#�3�f��B�6��S���f��B�vV�v�C�s�FF��s�7����&�&FW”�&F�W3�7��v��FR�76S���w&#��V�6VC��7����FC���G#��G”7G��S�&&6�w&�V�B�6���#�4c�c�d”#��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�F�’�WF�FR�2��BVffV7F�fR��V��Rv�F��ǖ7�7F�2�f’�7��G&��S��FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�5U$��T�B��B5U$��T�B�2F�B��B7G&F�g�f�”4�2�6��VB�F�ֆVBVff�67�FF��4�2F�V�G2�2Ɩ֗FVB��’6W’fF����&W�’G27VvvW7B6�֖�”vV�v�B��73��V6��7F�2&V6���r���&�fVB��7VƖ�6V�6�F�f�G��WF�FR&VGV7F���7W�’G2Vff�67��’WB��v��VƗG�$5BFF��4�2���ǒ�V�F���2�2�6���rf�”&�F�G’Vw2���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#��7�7G��S�&F�7�����Ɩ�R�&��6��&6�w&�V�C�4S�SC�&�&FW#��6�ƖB4�#dC�6���#�3�f��B�6��S���f��B�vV�v�C�s�FF��s�7����&�&FW”�&F�W3�7��v��FR�76S���w&#��V�6VC��7����FC���G#��G#��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�t��G’Vw2��7&V6R&�6��bv��&�FFW”F�6V6S��FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#��7B��&�WB6fWG�FF6��rv��&�FFW”�&�Ɩ’�WfV�G2B6�֖�”&FW2F��6V&���$5G2�’WB&V��v�&�B&W�’G27VvvW7B�76�&�R6�v���F��Vv�6��f�V�FVB’�&�BvV�v�B��72�v��6��G6V�b��7&V6W26���VƗF��6�2&�6�����6��6V�7W2��6W6ƗG��&V6��&�RF�6�V�6V�F�V�G2��&�Ɩ’�6�Ɩ27��F��2’WB��BF�f��BF�W&�&6VB��7W’&V�BWf�FV�6R���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#��7�7G��S�&F�7�����Ɩ�R�&��6��&6�w&�V�C�4S�SC�&�&FW#��6�ƖB4�#dC�6���#�3�f��B�6��S���f��B�vV�v�C�s�FF��s�7����&�&FW”�&F�W3�7��v��FR�76S���w&#��V�6VC��7����FC���G#��G”7G��S�&&6�w&�V�B�6���#�4c�c�d”#��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�6V�v�WF�FR�2dD&�f�f�”�’7G’V7F�fR6�VW�V�F�’�WF�FRF�W2��C��FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�E%TR�6V�v�WF�FRv2&�fVBf�”�4���V�R##B&6VB��F�R4�TUG&��6��v��r3�R&VGV7F��������F�’�WF�FR�2��B6�Vv�BF��2��F�6F����F��2&W&W6V�G2vV�V��R6Ɩ�6�Gf�FvRf�”6V�v�WF�FR���4�7V6�f�2�V�F���2���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#��7�7G��S�&F�7�����Ɩ�R�&��6��&6�w&�V�C�43�SdCC�&�&FW#��6�ƖB3Tc�#tc�6���#�3�f��B�6��S���f��B�vV�v�C�s�FF��s�7����&�&FW”�&F�W3�7��v��FR�76S���w&#�7W�’FVC��7����FC���G#��G#��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�F�’�WF�FRv���&W�6R6V�v�WF�FR&V6W6R�Bw2��&R�FV�C��FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#���B�V6W76&�ǒ��W2�F�’�WF�FR&�GV6W2��&RvV�v�B��72�’WB6V�v�WF�FR�24T�T5B�5b�WF6��RFF��F�’�WF�FRF�W2��B�WB�6�7B�66W72�6���V�F��r�&�6�W2ff�”6V�v�WF�FR���B��F�f�GV�F��W&&�ƗG�v�������f�VV�6RF�F�����&�WB6�&Rv���Ɩ�Vǒ&V���7ƗB&WGvVV�&�F�6���V�G2f�”�V’2���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#��7�7G��S�&F�7�����Ɩ�R�&��6��&6�w&�V�C�4S�SC�&�&FW#��6�ƖB4�#dC�6���#�3�f��B�6��S���f��B�vV�v�C�s�FF��s�7����&�&FW”�&F�W3�7��v��FR�76S���w&#��V�6VC��7����FC���G#���F&�Sࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#��#�#�F�RfW&F�7B&FvW2&�fRW6RF�Rf����v��rFVf��F���3��7�7G��S�&F�7�����Ɩ�R�&��6��&6�w&�V�C�43�SdCC�&�&FW#��6�ƖB3Tc�#tc�6���#�3�f��B�6��S���f��B�vV�v�C�s�FF��s�7����&�&FW”�&F�W3�7��v��FR�76S���w&#�7W�’FVC��7�����v��VƗG�$5BFF�”�WF��Ǘ6W27W�’BF�R6�����7�7G��S�&F�7�����Ɩ�R�&��6��&6�w&�V�C�4S�SC�&�&FW#��6�ƖB4�#dC�6���#�3�f��B�6��S���f��B�vV�v�C�s�FF��s�7����&�&FW”�&F�W3�7��v��FR�76S���w&#��V�6VC��7���F�R6����2’F��ǒG’VR�”6��FW�B�FWV�FV�C�F�RWf�FV�6R�2֗�VB�”��6���WFR��7�7G��S�&F�7�����Ɩ�R�&��6��&6�w&�V�C�4CDSDCC�&�&FW#��6�ƖB3t�t�6���#�3�f��B�6��S���f��B�vV�v�C�s�FF��s�7����&�&FW”�&F�W3�7��v��FR�76S���w&#���B7W�’FVC��7���7W’&V�BWf�FV�6R6��G&F�7G2F�R6�����”F�R6���77V�W2W&��V�6R�vV�W&Ɨ�&�ƗG���B7W�’FVB’�FF���ࠣ�7G��S�’FW�B�Ɩv�&�v�C��&v�㣇�3’�#���&Vc�”7F�2″7G��S�&f��B�6��S�7��6���#�3Tccssc�FW�B�FV6�&F������R#�(i&6�F�6��FV�G3����������w��F����ࠣ���w��F������F�b7G��S�&&6�w&�V�C�3cD3T3�&�&FW”�&F�W3����FF��s�3’�#����&v��C��FW�B�Ɩv�6V�FW”#��7G��S�&f��B�f֖Ǔ���R�7�7FV��&Ɩ��57�7FV�f��B�u6Vv�RT�r�&�&�F��6�2�6W&�c�f��B�6��S�#��f��B�vV�v�C�s�6���#�4dddddc��&v����Ɩ�RֆV�v�C��B#�F�R&W6V&6���fW2f7B�vR&VB���b�B6���RF��wB�fRF������7G��S�&f��B�f֖Ǔ���R�7�7FV��&Ɩ��57�7FV�f��B�u6Vv�RT�r�&�&�F��6�2�6W&�c�f��B�6��S�W��6���#�4#�C�c��&v��#��Ɩ�RֆV�v�C��b#��Wr6���V�B&Wf�Ww2�Wf�FV�6RWFFW2��B&�F�6���Ǘ6�2( B6�W&6VB�6�FVB��Bw&�GFV�f�”V��Rv��7GV�ǒ&VBF�R7GVF�W2������&Vc�&�GG3���WF�F��w2�7V’7F6��6���7V’67&�&R”F&vWC�%�&��”&V��&���V�W””7G��S�&F�7�����Ɩ�R�&��6��&6�w&�V�C�4dddddc�6���#�3cD3T3�f��B�6��S�W��f��B�vV�v�C�s�FF��s�’�3’��&�&FW”�&F�W3�g��FW�B�FV6�&F������S��WGFW”�76��s��7�#�7V’67&�&RF�WF�F��w2vVV�Ǔ�����F�c�����w��F����ࠣ���w��VF��r���ƃ”6�73�’w�&��6�ֆVF��r#�6&F��f67V�”Wf�FV�6S�v�W&R6V�v�WF�FR�VG3���#�����w��VF��r��ࠣ���w��F������7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�bvV�v�B��72vW&RF�R��ǒ6��6�FW&F����F�’�WF�FRv�V�B&RF�R6�V”v���W”�’WBvV�v�B��72�2��BF�R��ǒ6��6�FW&F����F�R��7B���’F�B���r�FW&��WF6��R�27W’f�f�( F�”��&R&V6�6Vǒ�&VGV7F��������”GfW’6R6&F��f67V�”WfV�G2��4R��v��6���6�VFW2���fF�ז�6&F����f&7F�������fF�7G&��R��B6&F��f67V�”FVF����ࠣƃ27G��S�&6���#�3$3S#�#�f��B�6��S�#’��f��B�vV�v�C�s��&v��#��’�#�F�R4T�T5BG&���6V�v�WF�FR����3ࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#����fV�&W”##2���f���&F�6�V&Ɨ6�VB4T�T5B���F�&�6&F��f67V�”�WF6��RG&��V�&��Ɩ�rr�cB����F�&WF�2GV�G2v�F�W7F&Ɨ6�VB6&F��f67V�”F�6V6R�”��v��&�6�6&F��f67V�”F�6V6R�vR(�SS�BB�V7B��R���”&�6�f7F�”7V6�2��W’FV�6����G�6Ɨ�FV֖��”6�����r����v�F�$Ԓ(�S#r�r��+”���vW”F��G��6��&W6�G�G&��2�&Vf�V7F��rF�RV��6�2��W��7F��r5bF�6V6R��’F�6��G2vW&R&�F�֗�VBF�6V�v�WF�FR”�B�r��6RvVV�ǒ�”�6V&���Bf����vVBf�”�VF���b3B���F�2���ࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�F�R&��’�V�G���N( C2����B�4R����fF�ז�6&F����f&7F�������fF�7G&��R��”6&F��f67V�”FVF��( Gv2&VGV6VB’�#Rv�F�6V�v�WF�FR��”���RR4��c�( 3�B��F�RWfV�B&FRv22�R��F�R6V�v�WF�FRw&�WfW’7W2B�bR��F�R�6V&�w&�W�fW”3B���F�2�6�’&W7��F��rF�&�WBWfV�B&WfV�FVBW”#RF�V�BזV’2�F��2�2F�Rf�’7B6&F��f67V�”�WF6��RG&��WfW”F�6��rF�Bt��&V6WF�”v��7B&VGV6W2��&&�F�G��B��’FƗG�������F�&WF�2GV�G>( F�V�F���v�W&R6&F��f67V�”&�6�f7F�’2&RG&�fV�’��&W6�G�&F�W”F��F�&WFW2���ࠣ�F�b7G��S�&&6�w&�V�B�6���#�4TcTc�&�&FW”��VgC�G�6�ƖB3$�Cs��&�&FW”�&F�W3�G��FF��s���#G���&v��#�#��#��7G��S�&f��B�f֖Ǔ�tfV�”�W�Bv�&�Br�tƖ&W&F���6�2r�6�2�6W&�c�f��B�6��S���f��B�vV�v�C�s�6���#�3$�Cs���WGFW”�76��s��W��FW�B�G&�6f�&ӧWW&66S��&v���#����V�vƗ6�����7G��S�&f��B�6��S�W��Ɩ�RֆV�v�C��s�6���#�3c#�33��&v��#�4T�T5Bv2�76�fR�r�cBV��R���7FVB�V’2�3B���F�2�VF����B6�VC�F�W26V�v�WF�FR&WfV�B�V’BGF6�2�B7G&��W2������F�&WF�2V��Rv�F�W��7F��r�V’BF�6V6R�”&�6�f7F�’3��7vW#��W2�#R&VGV7F����F�Bw2�VvR�F��2�2��B�W7BvV�v�B��72��^( GF��2�2��’FƗG�FF������F�cࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#���F&ǒ�4T�T5BV�&���VB&VF�֖��Fǒ����F�&WF�2F�V�G2���ǒ”R�BF�&WFW2B&6VƖ�R���B�V�&6VƖ�R$Ԓv23R�r�r��+.( F�&W6R’WB��BF�RW�G&V�Vǒ�&W6R�V�F���2G��6��b5DU�B5U$��T�B�F�R�V6��6��b&V�Vf�B�2Ɩ�Vǒ�V�F�f7F�&�âvV�v�B��7266�V�G2f�”6��R�’WB��B����bF�R�4R&VGV7F�����F�W”�FV�F���V6��6�2��6�VFR��&�fVB&���B&W77W&R�&VGV6VB��f���F������&�fVBF�W&�vV�2G�6Ɨ�FV֖��BF�&V7B6&F�2VffV7G2���ࠣƃ27G��S�&6���#�3$3S#�#�f��B�6��S�#’��f��B�vV�v�C�s��&v��#��’�#�5U%52�5d�B�F�’�WF�FR��7FGW2V�F��s���3ࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�VƒƖ�ǒ�2V�&���VB5U%52�5d�B�6&F��f67V�”�WF6��RG&���bF�’�WF�FRR�r��GV�G2v�F�G�R”F�&WFW2�BW7F&Ɨ6�VB6&F��f67V�”F�6V6R�”��v��&�6�fVGW&W2�V�&����V�B6��6VB��##B�’WB&W7V�G2�fR��B�WB&VV�V&Ɨ6�VB�W�V7FVB##^( 3##b��V�F��F�V��F�&V7B6&F��f67V�”&V�Vf�BFFf�”F�’�WF�FR������F�&WF�2�V�F���2F���BW��7B���ࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�F��27���WG’��2���’F�C��b��R&R6���6��r&WGvVV�6V�v�WF�FR�BF�’�WF�FR��B��R�fR6&F��f67V�”F�6V6R�”��v�5b&�6��6V�v�WF�FR�27W’&V�FǒF�R��ǒ�F���v�F�&�7V7F�fR�WF6��RG&��FF6��v��r�4R&VGV7F����F�’�WF�FR���fRF�R6�R&V�Vf�B��”w&VFW”��’WB��Rv�V�B&R����rF�B6���6R&6VB��vV�v�B��727WW&��&�G����R���B��5b�WF6��RFF���ࠣ�F�b7G��S�&&6�w&�V�C�4dTctc�&�&FW#�’�6�ƖB43C�43�&�&FW”�&F�W3�G��FF��s�G�����&v��#�#��#��7G��S�&f��B�6��S�G��6���#�3TcCc#��&v���f��B�vV�v�C�c#�Wf�FV�6RF�W#�4T�T5B�2�&vR�&�F�֗�VB�F�V&�R�&Ɩ�B��6V&��6��G&���VBG&��v�F��&B�WF6��W2��4R�������F�&WF�2�V�F����F��2�2F�W”Wf�FV�6^( F2v��B2�BvWG2�5U%52�5d�B&W7V�G2v���&RF�W”Wf�FV�6R��6RV&Ɨ6�VB�V�F��F�V���6���2&�WBF�’�WF�FRw25b&V�Vf�B&R7V7V�F�fR������F�cࠣ�7G��S�’FW�B�Ɩv�&�v�C��&v�㣇�3’�#���&Vc�”7F�2″7G��S�&f��B�6��S�7��6���#�3Tccssc�FW�B�FV6�&F������R#�(i&6�F�6��FV�G3����������w��F����ࠣ���w��VF��r���ƃ”6�73�’w�&��6�ֆVF��r#�6fWG�&�f��W26��&VC���#�����w��VF��r��ࠣ���w��F������7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�&�F�6V�v�WF�FR�BF�’�WF�FR&RvV�W&�ǒvV���F��W&FVB�’WB6fWG�&�f��W2&R��B�FV�F�6��&V��r�26��&V�V�6�fR6fWG�6��&�6��F&�R�f����vVB’�FWF��VBF�67W76����bV6�F������ࠣ�F&�R7G��S�’v�GF��S�&�&FW”�6���6S�6���6S��&v��#G�#��G#��F�7G��S�&&6�w&�V�B�6���#�3cD3T3�6���#�4dddddc�f��B�vV�v�C�s�FW�B�Ɩv��VgC�FF��s�’�g��&�&FW”�&�GF�ӣ’�6�ƖB3cD3T3�f��B�6��S�G�#�6fWG�F������F���F�7G��S�&&6�w&�V�B�6���#�3cD3T3�6���#�4dddddc�f��B�vV�v�C�s�FW�B�Ɩv��VgC�FF��s�’�g��&�&FW”�&�GF�ӣ’�6�ƖB3cD3T3�f��B�6��S�G�#�6V�v�WF�FR�5DU&�w&ғ��F���F�7G��S�&&6�w&�V�B�6���#�3cD3T3�6���#�4dddddc�f��B�vV�v�C�s�FW�B�Ɩv��VgC�FF��s�’�g��&�&FW”�&�GF�ӣ’�6�ƖB3cD3T3�f��B�6��S�G�#�F�’�WF�FR�5U$��T�B&�w&ғ��F���F�7G��S�&&6�w&�V�B�6���#�3cD3T3�6���#�4dddddc�f��B�vV�v�C�s�FW�B�Ɩv��VgC�FF��s�’�g��&�&FW”�&�GF�ӣ’�6�ƖB3cD3T3�f��B�6��S�G�#���FW3��F����G#��G”7G��S�&&6�w&�V�B�6���#�4c�c�d”#��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#��7G&��s��W6V��7G&��s���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�#RR��6V&��R���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�32R��6V&��R���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�F�’�WF�FR��v�W#�W7V�ǒG&�6�V�BGW&��rF�G&F�����FC���G#��G#��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#��7G&��s�f�֗F��s��7G&��s���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�BR��6V&�R���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�rR��6V&�R���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�F�’�WF�FR��v�W#���vV�V�Bv�F�6��vW”F�G&F�����FC���G#��G”7G��S�&&6�w&�V�B�6���#�4c�c�d”#��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#��7G&��s�F�’&�V��7G&��s���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#��R��6V&�R���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#��R��6V&�R���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�6�֖�”��6�FV�6S�W7V�ǒ֖�C��FC���G#��G#��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#��7G&��s�6��7F�F�����7G&��s���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�#”R��6V&��R���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�#RR��6V&��R���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�6�֖�#��gFV�6��7W’&V�Bv�F�&VGV6VBWF�FR�VF��s��FC���G#��G”7G��S�&&6�w&�V�B�6���#�4c�c�d”#��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#��7G&��s�7WFR�7&VF�F�2�&W�’FVB���7G&��s���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�f�C��R�66R��5DU���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�f�C��R�6�֖�”F��6V&�&6VƖ�R&�6����FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#���6�v��&�fR&6VƖ�S�6�72v&��r&V���2�&R�6Ɩ�6�FF���FC���G#��G#��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#��7G&��s�F��&��B2�6V��v&��s��7G&��s���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�6�72&�6��&��v&��r�&�FV�BFF���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�6�72&�6��&��v&��r�&�FV�BFF���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#���6��f�&�VB�D2���V��3�6��G&��F�6FVB���T�$�$”�”W’6����D2��7F�’���FC���G#��G”7G��S�&&6�w&�V�B�6���#�4c�c�d”#��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#��7G&��s�v��&�FFW”�&�Ɩ’�WfV�G3��7G&��s���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#��bRg2�rR�6V&��5DU��6�v����&V��v�&�BFF��FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#��bRg2�rR�6V&��5U$��T�B����6�v��&�fR�6V&���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�6V�v�WF�FR6�v����&Vf�V7B&�BvV�v�B��73�6W6ƗG�V�6�V#��FC���G#��G#��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#��7G&��s�7WFR��F�W���W’���7G&��s���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�֖���6�v�ò��B��7&V6VBg2��6V&���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�֖���6�v�ò��B��7&V6VBg2��6V&���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�&�F�&WV�&R6WF�����f��V�RFW�WF�����W6V�f�֗F��r���FC���G#��G”7G��S�&&6�w&�V�B�6���#�4c�c�d”#��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#��7G&��s��V��72��73��7G&��s���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#��^( 3b�r�V��#( 3#RR�bF�F���72���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#��^( 3b�r�V��#( 3#RR�bF�F���72���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�6�֖�#�&W6�7F�6RG&���r֗F�vFW2��73��FC���G#��G#��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#��7G&��s䇗�vǖ6V֖�����F�&WF�2F�V�G2���7G&��s���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�&&R�f�C��RR���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�&&R�f�C��RR���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�t��”v�V6�6R�FWV�FV�7�&�f�FW26fWG��&v����FC���G#��G”7G��S�&&6�w&�V�B�6���#�4c�c�d”#��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#��7G&��s�6W&��W2GfW’6RWfV�G2�4R���7G&��s���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�2�R�6V�v�WF�FR�g2B�R��6V&���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�B�rR�F�’�WF�FR�g2B�bR��6V&���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�&�F�6�֖�”F��”��vW”F���6V&���FC���G#��G#��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#��7G&��s�FVF�2��6W6R���7G&��s���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�f�C��”R�&&R���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�f�C��”R�&&R���FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�����7&V6VB��’FƗG�6�v��g2��6V&���V�F�W”&�w&���FC���G#���F&�Sࠣƃ27G��S�&6���#�3$3S#�#�f��B�6��S�#’��f��B�vV�v�C�s��&v��#��’�#�v7G&���FW7F���F��W&&�ƗG����3ࠣ�F�b7G��S�&&6�w&�V�C�4dDc$c#�&�&FW”��VgC�G�6�ƖB4S3cCC�&�&FW”�&F�W3�G��FF��s���#G���&v��#�#��#��7G��S�&f��B�6��S���f��B�vV�v�C�s�6���#�4S3cCC��WGFW”�76��s��W��FW�B�G&�6f�&ӧWW&66S��&v���#�6fWG��W’C����7G��S�&f��B�6��S�W��Ɩ�RֆV�v�C��s�6���#�3c#�33��&v��#�v7G&���FW7F���GfW’6RVffV7G2��W6V�f�֗F��r�F�’&�V�6��7F�F���&RF�R��7B6�����&V6��F�V�G2F�66��F��VRt���t�”v��7G2&V�GW&Vǒ�F�’�WF�FR6W6W2��&R�W6V�Bf�֗F��rF��6V�v�WF�FR�Ɩ�Vǒ&V6W6R�b�G2w&VFW”�FV�7��BGV�&V6WF�”7F�fF����6��vW”F�G&F����W�FV�FVB�fW”#vVV�2&F�W”F��bvVV�2��B&�7F�fR6�V�6VƖ�r6�&VGV6RF�66��F��VF���������F�cࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#��W6VffV7G2#^( 332R�bW6W’3��B�2W7V�ǒG&�6�V�B�V�2BvVV�2N( 3��bV6�F�6RW66�F�����B��7BF�V�G2v��6���WFRF�G&F���&W�’B��&�fV�V�B’�vVV�n( 3#�f�֗F��r�2�W726������N( 3rR��BG��6�ǒ��F�6FW2F�BF�6RW66�F����2F��&�Bf�”F�B��F�f�GV����vV�V�B��6�VFW26��v��rF�G&F����F���r��V7F���2���V�G�7F��6��&VGV6W2�W6V��6��RF�V�G2��F�WF’���F�f�6F���2�6���W”���&Rg&WVV�B�V�3�f��F��r��v��fBf��G2���B��6WfW&R66W2�FV��&’�F�6R&VGV7F����”�F�V�WF�2�VF�6F�����WF�6��&֖FR���F�6WG&���F�Rt�7��F��2F���B&VF�7BVff�67�( F��F�V�G2v�F�6WfW&R�W6V7F���6��WfR7V’7F�F��vV�v�B��72��B��v�F�֖����W6V�6�&W7��BvV�����ࠣƃ27G��S�&6���#�3$3S#�#�f��B�6��S�#’��f��B�vV�v�C�s��&v��#��’�#�F��&��B2�6V��v&��s���rv�’&�VB6��V�B��R&S����3ࠣ�F�b7G��S�&&6�w&�V�C�4dDc$c#�&�&FW”��VgC�G�6�ƖB4S3cCC�&�&FW”�&F�W3�G��FF��s���#G���&v��#�#��#��7G��S�&f��B�6��S���f��B�vV�v�C�s�6���#�4S3cCC��WGFW”�76��s��W��FW�B�G&�6f�&ӧWW&66S��&v���#�6fWG��W’C����7G��S�&f��B�6��S�W��Ɩ�RֆV�v�C��s�6���#�3c#�33��&v��#�&�F�6���V�G26”�&�6��&��v&��rf�”F��&��B2�6V��VffV7G2�&�FV�B6&6���vV�6�G�7GVF�W26��vVBF�6R�FWV�FV�B2�6V����W’�6��B�VGV��’�F��&��B6&6������D2�B��v�F�6W2��V��&V�Wf�6R�b&�FV�B2�6V��&�ƖfW&F����2FV&FVB���6��f�&�VB�D266R�2&VV�GG&�’WFVBF�V�F�W”6���V�B���b֖�Ɩ��F�V�B�W��7W&W2�&�F�G’Vw2&R6��G&��F�6FVB��W’6����”f֖ǒ��7F�’��b�D2�”�V�F��RV�F�7&��R�V��6�G�R”��T�$��T�$”�������F�cࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�F�R�&�6���v�2�V6��6��b&�FV�B2�6V��&�ƖfW&F����2��BgV�ǒV�FW’7F��N( Gv�WF�W”t��”6�v�Ɩ�rF�&V7Fǒ7F��V�FW226V��2��”v�WF�W”�fb�F&vWBVffV7G2�R�r��f�6�6�F���&V6WF�”�G&�fR&�ƖfW&F�������’F�Fǒ��V��2�fRf”fWvW”2�6V��GV��’27��F�V�W6ǒF��&�FV�G2��B�V6��7F�2FFF���B6�V&ǒG&�6�FR7&�727V6�W2��7B��&�WB7W’fV����6R�fW”�2�V’2��֖�Ɩ��2�bF�V�G2�2��B&WfV�VB�V���D26�v���FW7�FR�&�6�f�v���6R7V6�f�6�ǒ���F�&��rf�”F��&��BWfV�G2�F��2&wVW2F�BV�F�W”F�R&�FV�B6�v��F�W2��BG&�6�FR��”�b�BF�W2�F�R&�6��2W�G&V�Vǒ��r���ࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�6Ɩ�6�&7F�6S�F�V�G2v�F�W’6����”f֖ǒ��7F�’��b�D2�”�T�”6��V�B��B&V6V�fRV�F�W”G’Vr�F�V�G2v�F��WBF��2��7F�’�6�&R&V77W&VBF�B7W’&V�BWf�FV�6R7VvvW7G2F�R&�6��2F�V�&WF�6�&F�W”F��FV���7G&FVB�&�WF��R6�6�F���67&VV��r�2��B&V6���V�FVB’��6�6�WG���Bv�V�B&WV�&R&6VƖ�R�BW&��F�2FW7F��r�’WBV�6�V”F�&W6���Bf�”��FW’fV�F�����BV�G&6�V�B67&VV��r�bF�RF��&��B�2��B7F�F&B&7F�6RV��W727��F��2FWfV���F�Rv&��rv���Ɩ�VǒW’6�7B2���r2F�R&V6Ɩ�6�FFW��7B�WfV��b6Ɩ�6�6�v��&V���2’6V�B���ࠣƃ27G��S�&6���#�3$3S#�#�f��B�6��S�#’��f��B�vV�v�C�s��&v��#��’�#�v��&�FFW”F�6V6S��V�W&v��r6�v������3ࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�5DU&W�’FVBv��&�FFW”�&V�FVBGfW’6RWfV�G2B�bR��6V�v�WF�FRfW’7W2�rR���6V&�( F�V&ǒ”�f��B��7&V6R��7B��&�WB&W�’G2g&��6���V�F��r�&�6�W2�B&VFF�Bf�’V�2�V6F�F�ǒ&W�’B&�Ɩ’�6�Ɩ2�B6���V7�7F�F�2��t��W6W’2�F�’�WF�FR5U$��T�BG&��26��vVBv��&�FFW”WfV�G2B�bR��F�’�WF�FRfW’7W2�rR�6V&�( F��6�v�����ࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#���’F�B6��f�V�FW#�&�BvV�v�B��72�b�6W6R��7&V6W26���VƗF��6�2&�6��&�BvV�v�B��72FW�WFW2F�Rv��&�FFW”w2&��RƗ�B&W6W’fR�&VF�7�6��rF�&��R7F6�2�B7F��Rf�&�F�����B�2�W6�&�RF�B6V�v�WF�FR�v�F��G2�&vW”7V�V�F�fRvV�v�B��72��5DUG&��2�6��ǒ&Vf�V7G2F�R&6VƖ�R&�6��b&�BvV�v�B��72&F�W”F��G’Vr�7V6�f�2VffV7B�F�’�WF�FRw26�֖�”vV�v�B��72�WB��vW”v��&�FFW”WfV�B&FR6��2F��2��F�VW7F���( GW&�2F�’�WF�FRw26��vW”vV�v�B��72G&�V7F�’��#vVV�g2�bvVV�F�G&F���&VGV6W2v��&�FFW”7G&W72��”W&�2F�RG&��2F�ffW”���V�F���6�&7FW&�7F�72�vR�&6VƖ�R$Ԓ�&6VƖ�Rv��&�FFW”V�G&6�V�G2��F�RG’WF��3�6W6ƗG��2V�6�V”�’WB6Ɩ�6�v&V�W72�2v’&�FVB�F�V�G2v�F�7F�fR&�Ɩ’�6�Ɩ2�”F�7V�V�FVB6���VƗF��6�26��V�B&�&&ǒf��BF�W6RG’Vw3�7��F��F�2v��7F��W2&R��B�’6��WFR6��G&��F�6F������ࠣ�7G��S�’FW�B�Ɩv�&�v�C��&v�㣇�3’�#���&Vc�”7F�2″7G��S�&f��B�6��S�7��6���#�3Tccssc�FW�B�FV6�&F������R#�(i&6�F�6��FV�G3����������w��F����ࠣ���w��VF��r���ƃ”6�73�’w�&��6�ֆVF��r#�F�RvV�v�B&Vv��VW7F������#�����w��VF��r��ࠣ���w��F������7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�F��2�2W&�2F�R��7B���’F�B6V7F����bF��2’F�6�R�&�F�6V�v�WF�FR�BF�’�WF�FR&�GV6R��&W76�fR6��’B�FW&�vV�v�B��72�’WBv�B�V�2v�V���R7F�F���rF�RG’Vs�F�R�7vW”&W6�W2��rvR6��V�BF���&�WBF�W6R6���V�G>( F��B2’vV�v�B��727W&W2�”’WB26�&��2F�6V6RG&VF�V�G2&WV�&��r��v���r��vV�V�B���ࠣƃ27G��S�&6���#�3$3S#�#�f��B�6��S�#’��f��B�vV�v�C�s��&v��#��’�#�5DUC�6V�v�WF�FRF�66��F��VF����B&Vv�����3ࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�5DUBV�&���VB�”’F�6��G2v���B6���WFVBc�vVV�2�b6V�v�WF�FR”�B�rG&VF�V�B��5DU�F�W6R��F�f�GV�2F�V�vW&R&�F�֗�VBF�6��F��VR6V�v�WF�FR�”7v�F6�F��6V&�f�”�FF�F����S”vVV�2���R�V”�b�’6W’fF����7B�G&VF�V�B��BV�G’�F�F�RF�66��F��VF����6R�F�R6V�v�WF�FRw&�W�B��7B�V��bB�RR�bF�V�”&6VƖ�R&�G�vV�v�B�gFW”��R�V”�fb6V�v�WF�FR����6V&��F�W�&Vv��VB&����FVǒr��~( Gv��6�6�’&W7��G2F�&�WBSR�bF�RvV�v�BF�W��B��F��ǒ��7B�Gv��F��&G2�b&Vv��VBvV�v�Bv2fC���R�F��&Bv2�V�F�77VR�7VvvW7F��r’F��&WfW’6��b�V��72��72����ࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�’F�6��G2v��&V���VB��6V�v�WF�FR���F��VBF�V�”vV�v�B��72�6��f�&֖�rF�BF�RvV�v�B��72�FVR6��WfVB’�vVV�C�2��B’7FW”F�v&BW&��V�B��vW”vV�v�N( F�B�2G&VF�V�B�FWV�FV�BWV�Ɩ’&�V����F��VB’���v���rt��&V6WF�”v��6����ࠣ�F�b7G��S�&&6�w&�V�B�6���#�4TcTc�&�&FW”��VgC�G�6�ƖB3$�Cs��&�&FW”�&F�W3�G��FF��s���#G���&v��#�#��#��7G��S�&f��B�f֖Ǔ�tfV�”�W�Bv�&�Br�tƖ&W&F���6�2r�6�2�6W&�c�f��B�6��S���f��B�vV�v�C�s�6���#�3$�Cs���WGFW”�76��s��W��FW�B�G&�6f�&ӧWW&66S��&v���#����V�vƗ6�����7G��S�&f��B�6��S�W��Ɩ�RֆV�v�C��s�6���#�3c#�33��&v��#�v�V�V��R7F�VBF���r6V�v�WF�FR�F�W�v��VB&6���bF�RvV�v�BF�W��B��7Bv�F����V”�F��2�27’V6�âF�RG’Vrv�&�2v���R��RF�R�B��b��R7F����W”&�G�&WGW&�2F��G2&Wf��W2’6WB���B�”F��2�2��Bf��W&S�F��2�2F�R&����w��b�&W6�G���B�V�2��R�VVBF��VWF���rF�RG’VrF��VWF�RvV�v�B�fb������F�cࠣƃ27G��S�&6���#�3$3S#�#�f��B�6��S�#’��f��B�vV�v�C�s��&v��#��’�#�5U$��T�B�C�F�’�WF�FRF�66��F��VF����B&Vv�����3ࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�5U$��T�B�BV�&���VB�2’F�6��G2v���B6��WfVBvV�v�B��72��F�’�WF�FR��5U$��T�B��F�W6R��F�f�GV�2F�V�vW&R&�F�֗�VBF�6��F��VRF�’�WF�FR�r��”7v�F6�F��6V&��f�”S”vVV�2�&V�&�&ǒ�vV�v�B&Vv��v�F�F�’�WF�FRF�66��F��VF���v2��&R&���V�6VBF��v�F�6V�v�WF�FS�’F�6��G2v��7v�F6�VBF��6V&�&Vv��VB�V��bB�2�~( F&����FVǒ�RR�bF�V�”��F��vV�v�B��72�F�R7GVG�v2V&Ɨ6�VB��##B���V���&W6�G���V�����ࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�F��2F�ffW&V�6^( CSR&Vv��f�”6V�v�WF�FRfW’7W2�RRf�”F�’�WF�F^( F�27G&����r�v�����R���F�W6�2�2F�BF�’�WF�FRw2GV�t�”�t��”�V6��6�&�GV6W2FVWW”�WF&�Ɩ2&V��FVƖ�r�7V6�F�BF�R&�G�w2���V�7FF�2G&�fRF�&WGW&�F���v�W”6WG���B�27G&��vW”��FW&�F�fVǒ�’F�6��G2��F�’�WF�FR���fR6��WfVB��v�W”FVw&VR�bWF�FR7W&W76�����BF�W2F�WF’�F�W&V�6R���BW��F�66��F��VF���f6R��&R”WB&WGW&�F�&6VƖ�RWF�FR��”F�R�V�F���2��F�RGv�G&��26��ǒF�ffW&VB���WF&�Ɩ26�&7FW&�7F�72�F�R�V6��7F�2W���F���&V���2V�6�V”���ࠣ�F�b7G��S�&&6�w&�V�C�4dTctc�&�&FW#�’�6�ƖB43C�43�&�&FW”�&F�W3�G��FF��s�G�����&v��#�#��#��7G��S�&f��B�6��S�G��6���#�3TcCc#��&v���f��B�vV�v�C�c#�6Ɩ�6���Ɩ6F���F�’�WF�FR&�GV6W2��&RvV�v�B��72’WB�6�6��w2w&VFW”vV�v�B&Vv��W��F�66��F��VF����F��27VvvW7G2F�RG’Vrv�&�2��&R�vW&gV�ǒF�7W&W72WF�FRGW&��rG&VF�V�B�’WB��R&V6��R��&RFWV�FV�B���BF����F��vV�v�B��72�6V�v�WF�FR6��w2��&R��FW7BVffV7B��&�F�F�&V7F���2�F��2F�W2��B��R��R7WW&��#��B6��vW2F�R6Ɩ�6�6�7V�W2f�”F�V�G26��6�FW&��r���r�FW&�G&VF�V�B������F�cࠣƃ27G��S�&6���#�3$3S#�#�f��B�6��S�#’��f��B�vV�v�C�s��&v��#��’�#�F�R6�&��2F�6V6R��FV����3ࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�F�RvV�v�B&Vv��FFgV�F�V�F�ǒ&Vg&�R��rvR6��V�B6��6WGVƗ�R�&W6�G�G&VF�V�Bv�F�t���Bt�”v��7G2�F�W6R6���V�G2F���B&7W&R”�&W6�G��F�W���vR�B�F��2�2���v�W2F�&���B&W77W&R�VF�6F���3���RF�R�4R�憖&�F�”f�”��W’FV�6������W”&���B&W77W&Rf��2�B7F�26��G&���VBv���R��RF�R�B��Bv�V���R7F��&���B&W77W&R&WGW&�2F�&6VƖ�R��”��v�W”����RF���BW�V7BF�F�R&���B&W77W&R�VF�6F���f�”F�&VR���F�2�B�fRW&��V�B��&�Ɨ�F����6�֖�&ǒ�t���t�”v��7G26��V�B&R6��6�FW&VB6�&��2F�6V6R��vV�V�BF���2���ࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�F��2�2V��&��W2��Ɩ6F���2f�”F�V�B6�V�6VƖ�r�6�7B��FVƖ�r��B�VF�6�WF��72��bF�V�B6�2�$6��7F�gFW”�V#�”F�R���W7B�7vW”�3�&�&&ǒ��B�V��W726��WF���r�26��vVB&�WBF�V�”V�FW&ǖ��r��6����w��v��6��2V�Ɩ�Vǒv�F��WB&�f�V�BƖfW7G��R��FW’fV�F����F�RVW7F���F�V�&V6��W3��2�Bv�’F�F���r���V7F�����6RvVV�ǒ��FVf��FVǒF����F��^( 3#”�rvV�v�B��73�f�”��F�V�G>( G’F�7V�&ǒF��6Rv�F�vV�v�B�&V�FVB6���&&�F�F�W2�6�VW�V�����BF�6V6R��”7�6����v�6�F�7G&W7>( GF�R�7vW”�2�W2�f�”�F�W’2�F�R��v���r6�7B�B�76�R�WGvV�v�2F�R&V�Vf�B���ࠣ�7G��S�’FW�B�Ɩv�&�v�C��&v�㣇�3’�#���&Vc�”7F�2″7G��S�&f��B�6��S�7��6���#�3Tccssc�FW�B�FV6�&F������R#�(i&6�F�6��FV�G3����������w��F����ࠣ���w��VF��r���ƃ”6�73�’w�&��6�ֆVF��r#�&7F�6�6��6�FW&F���3�6�7B�66W72��B6���6��s���#�����w��VF��r��ࠣ���w��F������7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�F�R6Ɩ�6�FF&R6�V#�F�’�WF�FR&�GV6W2��&RvV�v�B��72�6V�v�WF�FR�26&F��f67V�”�WF6��RFF�’WBF�R&V��v�&�BFV6�6����gFV����vW2��6�7B�f��&�ƗG���B��F�f�GV�F��W&&�ƗG��F��26V7F����f�vFW2F�B��G66R���ࠣƃ27G��S�&6���#�3$3S#�#�f��B�6��S�#’��f��B�vV�v�C�s��&v��#��’�#�6�7B�B��7W&�6R��G66S���3ࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�’&�B���RvVv�g��6V�v�WF�FR�Ɨ7B&�6R�2&����FVǒC�c�f�”B�vVV�7Wǒ�BV�2�b”�B�r��’&�B���R�W&�V�B�F�’�WF�FR�Ɨ7B&�6R�2&����FVǒC�c�f�”B�vVV�7Wǒ���vWfW”�F�W6RƗ7B&�6W2�V�ƗGF�^( F7GV��WB��b��6�WB6�7BFWV�G2����7W&�6R6�fW&vR�6��76�7F�6R&�w&�2��B6���V�F��r�&�7�&�6��r���ࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�f�”��7W&VBF�V�G3���f���&F�6�w2vVv�g�6f��w26&B626���V�G2BC#S����F�f�”6���W&6��ǒ��7W&VBF�V�G2��BC#R����F�f�”F��6R���VF�6&R�f�”VƖv�&�R&V�Vf�6�&�W2��VƒƖ�ǒw2��V�&�6f��w26&B�W6VB�fb��&V�f�”�&W6�G���”f�”F�R�W&�V�B��F�6F���626��2BC#R����F���6���W&6����7W&�6R�BCS����F����VF�6&R���vWfW”���7W&�6Rf�&�V�&�W2f’�v�FVǞ( G6��R��7W&�6R��2F���B6�fW”V�F�W”G’Vrf�”�&W6�G��F�W���6�fW”F�RF�&WFW2��F�6F���2���B&��”WF��&��F����2�gFV�&WV�&VB���ࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�f�”V��7W&VB�”V�FW&��7W&VBF�V�G3�6���V�F��r�&�6�W2�ffW”6V�v�WF�FRB&�Vv�ǒC( 2C#W”���F���BF�’�WF�FRBCS( 2C3W”���F��FWV�F��r��F�R�&�7��6�W&6��r��B��Vf7GW&��r6��6�7FV�7��6V�v�WF�FR6���V�F��r�&�6�W2&R��&RW7F&Ɨ6�VB�B�V�W&�W2��V’2�b7Wǒ6���FWfV���V�B������r6V�v�WF�FR��&R&VƖ&ǒf��&�RB��vW”&�6W2�F�’�WF�FR6���V�F��rv26WfW&VǒF�7’WFVB’�F�RdD6��’FvRFW6�v�F����ƖgFVB���&6�##R��’WB7Wǒ6���2&R7F���&V’V��F��r2�b֖B�##R���ࠣƃ27G��S�&6���#�3$3S#�#�f��B�6��S�#’��f��B�vV�v�C�s��&v��#��’�#�6���V�F��r�&�7���G66R�BVƗG�6��6W&�3���3ࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�6���V�FVB6V�v�WF�FR�BF�’�WF�FR&R��BdD�&�fVBG’Vw3�F�W�&R6���V�FVB’�Ɩ6V�6VB�&�6�W2V�FW”7FFR�&�7�&�&B�fW’6�v�B�VƗG�f&�W2G&�F�6�ǒ�6��R6���V�F��r�&�6�W2���F��&�v�&�W2�ǗF�6�FW7F��r���v��W&f�&��6RƗV�B6�&��F�w&�����5�F�fW&�g��FV�7��BW&�G��7FW&��Rf��Ɩ�r&7F�6W2�7F&�ƗG�FW7F��r���F�W’2F�֖���VƗG�6��G&���F�RdD�2�77VVBv&��r�WGFW’2F�6���V�F��r�&�6�W2����rf�6R7FW&�ƗG�6���2�B6V�Ɩ�r&�GV7G2v�F�&7FW&��6��F֖�F����”��6�’&V7B�FV�7����ࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#���&6�##R�F�RdD&V��fVBF�’�WF�FRg&��F�R6��’FvRƗ7B�’WBF�’�WF�FR6���V�F��r�&�6�W2f6R��v���r6�W&6��r6���V�vW2�’VƲF�’�WF�FR�vFW”�2��Vf7GW&VB’�&V�F�fVǒfWr7WƖW’2v��&�ǒ��BvV��ƗF�6�f7F�’2���Vf7GW&��rFV��2��B&VwV�F�’�&’&�W’2�fR�WB7Wǒ6��7G&��VB�6V�v�WF�FR6���V�F��r�’�6��G&7B��2��&RW7F&Ɨ6�VB6�W&6��r�B�2��&Rv�FVǒf��&�R�F�V�G26���6��r6���V�FVB�VF�6F���26��V�BfW&�g�F�BF�R�&�7�6��GV7G2��2�FV�7�FW7F��r��V6�&F6��BV&Ɨ6�W2FW7B&W7V�G2F�F�V�G2���ࠣ�F�b7G��S�&&6�w&�V�C�4T$cTd3�&�&FW”��VgC�G�6�ƖB3DT�DS�FF��s�g�#���&v��#���&�&FW”�&F�W3�G�G�#��7G��S�&6���#�3DT�DS�f��B�6��S�’��f��B�vV�v�C�s��&v��g��FW�B�G&�6f�&ӧWW&66S��WGFW”�76��s��fV�#�6���V�F��r��FS����7G��S�&6���#�3c#�33�f��B�6��S�W��Ɩ�RֆV�v�C��s��&v��#�b��R6���6R6���V�FVB6V�v�WF�FR�”F�’�WF�FS���fW&�g�F�R�&�7��2fƖB�&�7�Ɩ6V�6S��”�6�f�”Wf�FV�6R�b��2FW7F��r6��v��r�FV�7���2�7F’Bv�F�.( 3BvVV�7WǒF�76W72F��W&&�ƗG�&Vf�&R6��֗GF��rF��&vW”�&FW’3��B�&W�’B�GfW’6RWfV�G2�”7W7V7FVB�FV�7��77VW2F���W”�V�F�6&R&�f�FW”�BF�RdD�VEvF6�&�w&�������F�cࠣƃ27G��S�&6���#�3$3S#�#�f��B�6��S�#’��f��B�vV�v�C�s��&v��#��’�#�v��6�F�V�G2&V�Vf�B��7Bg&��V6�����3ࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#��7G&��s�6���6R6V�v�WF�FR�b��S���7G&��s���ࠣ�V�7G��S�&�&v��#��FF��r��VgC�#G�#��ƒ7G��S�&�&v�����6���#�3c#�33�f��B�6��S�g��Ɩ�RֆV�v�C��r#�fRW7F&Ɨ6�VB6&F��f67V�”F�6V6R�”��v�5b&�6��4T�T5BG&��FF7W�’G2�4R&VGV7F�����Ɠ��ƒ7G��S�&�&v�����6���#�3c#�33�f��B�6��S�g��Ɩ�RֆV�v�C��r#�fR�’7G’V7F�fR6�VW�V�dD�&�fVB��F�6F���2�b�V�R##B���Ɠ��ƒ7G��S�&�&v�����6���#�3c#�33�f��B�6��S�g��Ɩ�RֆV�v�C��r#�&RV��7W&VB�”V�FW&��7W&VB�6���V�F��r�&�6�W2�fR��&R7Wǒ�B��vW”&�6W2���Ɠ��ƒ7G��S�&�&v�����6���#�3c#�33�f��B�6��S�g��Ɩ�RֆV�v�C��r#�&��&�F��R�’&�vW”Vff�67��&v��’WB�FV�F��ǒ��&R7F&�R���r�FW&�&W7��6S��Ɠ��ƒ7G��S�&�&v�����6���#�3c#�33�f��B�6��S�g��Ɩ�RֆV�v�C��r#�fR��”F��W&�6RF�t�6�FRVffV7G2�6V�v�WF�FR6W6W2�W72�W6VF��F�’�WF�FR���Ɠ���V�ࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#��7G&��s�6���6RF�’�WF�FR�b��S���7G&��s���ࠣ�V�7G��S�&�&v��#��FF��r��VgC�#G�#��ƒ7G��S�&�&v�����6���#�3c#�33�f��B�6��S�g��Ɩ�RֆV�v�C��r#�fR6���W&6����7W&�6Rv�F�&�’W7BF�’�WF�FR6�fW&vR�6�7B&’&�W”VƖ֖�FVB���Ɠ��ƒ7G��S�&�&v�����6���#�3c#�33�f��B�6��S�g��Ɩ�RֆV�v�C��r#�&��&�F��R����V�6��’B�FW&�vV�v�B��72�b�”W&6V�FvR���G2��&RF��6V�v�WF�FR���Ɠ��ƒ7G��S�&�&v�����6���#�3c#�33�f��B�6��S�g��Ɩ�RֆV�v�C��r#�fRG�R”F�&WFW2�&�F�5U$��T�B�”�B5U$��T�B�26��rW�6V��V�Bvǖ6V֖26��G&�“��Ɠ��ƒ7G��S�&�&v�����6���#�3c#�33�f��B�6��S�g��Ɩ�RֆV�v�C��r#�F��W&FRt�6�FRVffV7G2&V6��&ǒvV���F�W�v���&R��&R��FV�6R���Ɠ��ƒ7G��S�&�&v�����6���#�3c#�33�f��B�6��S�g��Ɩ�RֆV�v�C��r#�&Rv��Ɩ�rF�v�Bf�”5U%52�5d�B&W7V�G2&Vf�&R6��֗GF��r���r�FW&���b5b&�6��2&��V�B���Ɠ���V�ࠣ�7G��S�’FW�B�Ɩv�&�v�C��&v�㣇�3’�#���&Vc�”7F�2″7G��S�&f��B�6��S�7��6���#�3Tccssc�FW�B�FV6�&F������R#�(i&6�F�6��FV�G3����������w��F����ࠣ���w��VF��r���ƃ”6�73�’w�&��6�ֆVF��r#�7v�F6���r&WGvVV�F�V����#�����w��VF��r��ࠣ���w��F������7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�&V��v�&�B6Ɩ�6�&7F�6R�2�&VG�vV�W&FVBW�W&�V�6Rv�F�7v�F6���rF�V�G2&WGvVV�6V�v�WF�FR�BF�’�WF�FR�F�R&6�2&��6��W2&R7G&�v�Ff�’v&B�’WBF�RW�V7WF���&WV�&W2GFV�F���F�FWF�����ࠣƃ27G��S�&6���#�3$3S#�#�f��B�6��S�#’��f��B�vV�v�C�s��&v��#��’�#���v6��WBW&��B�VVFVC���3ࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�&�F�6���V�G2�fR6��’B��b�ƗfW2�^( 3rF�2���V��rF�BVffV7F�fR6��6V�G&F���2G&�6�v�f�6�Fǒv�F���( 3BF�2�bF�66��F��VF����F�W&R�2��6Ɩ�6�&F����Rf�”’v6��WBW&��B”&WGvVV�7v�F6���rg&����RF�F�R�F�W”���R6�F�V�&WF�6�ǒ7v�F6�F�R6�RvVV��R�r��7F�6V�v�WF�FR�7F’BF�’�WF�FRBF�R��vW7BF�6RF�Rf����v��rvVV�����vWfW”�F��2�2&&VǒF��R��&7F�6R���ࠣƃ27G��S�&6���#�3$3S#�#�f��B�6��S�#’��f��B�vV�v�C�s��&v��#��’�#���FF�’�&WF�G&F������3ࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�F�R7&�F�6����C��V���R�W7B&WF�G&FS��V���F�V�G26���B6��ǒ7v�F6�g&��6V�v�WF�FR”�B�rF�F�’�WF�FRR�r��F�R6�R��V7F����F�R�FV�7��&V6WF�”ff��G�����V7V�”vV�v�B��B�&�6����WF�72F�ffW”V��Vv�F�B6����rF�G&F���v������7B6W’F��ǒG&�vvW”6WfW&R�W6V�f�֗F��r��Bv7G&���FW7F���F�7G&W72���ࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�v�V�7v�F6���rg&��6V�v�WF�FRF�F�’�WF�FS�7F’Bv�F�F�’�WF�FR”�R�r�BF�G&FR�fW”#vVV�2�”�R(i”R(i”r�R(i”(i”R�r��v�V�7v�F6���rg&��F�’�WF�FRF�6V�v�WF�FS�7F’Bv�F�6V�v�WF�FR�#R�r�BF�G&FR�fW”bvVV�2��#R(i”�R(i”�(i”�r(i””�B�r��6��R6Ɩ�6��2�fRGFV�FVB&66V�W&FVB7v�F6���r”v�W&RF�RF�V�B7F�2��F�R���FV��6RF�6R�bF�Rf�’7BG’Vrf�”�W�G&���F��”Gv�v���RF�G&F��rF�R6V6��BG’Vr��&��V��F�V�7v�F6�W2��6RF�R�WrG’Vr�2B���FV��6R�F��2&�6��2�V6F�Fòf�&��FF&R�6���r���ࠣ�F�b7G��S�&&6�w&�V�B�6���#�4TcTc�&�&FW”��VgC�G�6�ƖB3$�Cs��&�&FW”�&F�W3�G��FF��s���#G���&v��#�#��#��7G��S�&f��B�f֖Ǔ�tfV�”�W�Bv�&�Br�tƖ&W&F���6�2r�6�2�6W&�c�f��B�6��S���f��B�vV�v�C�s�6���#�3$�Cs���WGFW”�76��s��W��FW�B�G&�6f�&ӧWW&66S��&v���#����V�vƗ6�����7G��S�&f��B�6��S�W��Ɩ�RֆV�v�C��s�6���#�3c#�33��&v��#�7v�F6���rG’Vw26�V�G26���R’WB&WV�&W2&WF�G&F������R�W7B7F’BBF�R��vW7BF�6R�bF�R�WrG’Vr�BF�G&FRW�WfV��b��RvW&R�&VG�������V�F�6R�bF�R��B��R�F��2F�W2n( 3#vVV�2�BFV��26��Wf��r���FV��6RF�6R�BvV�v�B��72��F�R�WrG’Vr������F�cࠣƃ27G��S�&6���#�3$3S#�#�f��B�6��S�#’��f��B�vV�v�C�s��&v��#��’�#�6Ɩ�6���F�6F���2f�”7v�F6���s���3ࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�v�V�֖v�B��R7v�F6��&V6��&�R��F�6F���2��6�VFS�����FWVFRvV�v�B��72&W7��6R����RG’Vr�F��Vv�c�( 3s”vVV�26��V�BV�6R&Vf�&R6��6�VF��r����&W7��6R���”���F��W&&�Rt�6�FRVffV7G2�7v�F6���rF�F�R�F�W”����&�fRF��W&&�ƗG��F��Vv�&�F�6W6R�W6V���2�6�7B�66W72�77VW2�7v�F6���rg&��’&�BF�6���V�F��r��”f�6RfW’6���B�6&F��f67V�”F�6V6RF�v��6�2�7v�F6���rF�6V�v�WF�FR�b7F’F��rF�’�WF�FR�F�v��4T�T5BFF���R�6�VW�VF�v��6�2�7v�F6���rF�6V�v�WF�FRf�”F�R&�fVB��F�6F������ࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�7v�F6���r6��V�B��B&RF��RƖv�Fǒ�”g&WVV�Fǒ�V6�7v�F6�V�F��2���F�2�b&WF�G&F���GW&��rv��6�F�RF�V�Bw2vV�v�B��72&�w&W72�2W76V�F��ǒW6VB�f�”��7BF�V�G2�7F���r��F�R��F��G’Vr�B�F�֗���rF�6R�2&VfW&&�RF�6�6��rF�R&&WGFW””G’Vr���ࠣ�7G��S�’FW�B�Ɩv�&�v�C��&v�㣇�3’�#���&Vc�”7F�2″7G��S�&f��B�6��S�7��6���#�3Tccssc�FW�B�FV6�&F������R#�(i&6�F�6��FV�G3����������w��F����ࠣ���w��VF��r���ƃ”6�73�’w�&��6�ֆVF��r#�v�B&�WB&WFG’WF�FS����#�����w��VF��r��ࠣ���w��F������7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�26V�v�WF�FR�BF�’�WF�FRF�֖�FRF�R�&W6�G��VF�6F�����G66R�b##R�F��&B6���V�N( G&WFG’WF�F^( F����2��F�R��&�����&WFG’WF�FR�2G&��v��7B�7F�fF��rt��”�t�”��Bv�V6v��&V6WF�”�v6u”�6��V�F�V�W6ǒ��B&W&W6V�G2F�R�W�Bg&��F�W”����7&WF���&6VB�&W6�G��&�6���w����ࠣƃ27G��S�&6���#�3$3S#�#�f��B�6��S�#’��f��B�vV�v�C�s��&v��#��’�#��V6��6��BV&ǒVff�67�FF���3ࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�&WFG’WF�FR�FWfV��VB’�VƒƖ�ǒ�FG2v�V6v��&V6WF�”v��6�F�F�RF�’�WF�FR�Ff�&��v�V6v���F�R6�V�FW”�&VwV�F�’���&���RF���7VƖ����7&V6W2�WF�2v�V6�6R&�GV7F����BV�W&w�W�V�F�GW&R�6�&��6�ǒ7F�fF��rv�V6v��&V6WF�’2v2��7F�&�6�ǒ6��6�FW&VBV�v�6R�&�6��b��W&vǖ6V֖��’WBF�Rv�V6�6R�FWV�FV�B�GW&R�bt��”6�v�Ɩ�r6��7G&��2��W&vǖ6V֖&�6����F�V�’��t�”�t��”�v6u”G&��Rv��6�6��V�B&�GV6RWfV�w&VFW”vV�v�B��72F��GV�t�”�t��”v��6����ࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#��6R��”FFg&���FR##26��vVB&WFG’WF�FRBF�R��v�W7BF�6W2&�GV6��r�V�vV�v�B��72�b#N( 3#RR���&W6R����F�&WF�2GV�G>( G7V’7F�F��ǒw&VFW”F��F�’�WF�FRw2#”�RR�5U$��T�B���B6V�v�WF�FRw2B�R�5DU����vWfW”��6R��”6��R6��W2vW&R6���W”�BG&��GW&F���6��’FW”F���6R���&�w&�2��6R���5T�ԕBG&��2&RV�FW’v��&W7V�G2&RW�V7FVB���FR##R�”##b�&WFG’WF�FR�2��B�WBdD�&�fVB�B&V���2��fW7F�vF�������ࠣƃ27G��S�&6���#�3$3S#�#�f��B�6��S�#’��f��B�vV�v�C�s��&v��#��’�#�V���v�2�B6��6W&�3���3ࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�v����6R���Vff�67��F6��6R��#�v�B�2F�R6fWG�&�f��S�v���v7G&���FW7F���6�FRVffV7G2&RWfV���&R&���V�6VC�v���v�V6v��&V6WF�”v��6���G&�GV6R��fV�&�6�2�R�r���FW&VBv�V6�6R���V�7F6�2��F�V�G2v�F�F�&WFW2��v���&WFG’WF�FR&W�6RF�’�WF�FR��”v����Bf��B�6�R��F�V�G2v��f��F�&W7��BFWVFVǒF�GV�v��7G3�F�R�7vW’2v���V�W&vR�fW”##^( 3##b���ࠣ�F�b7G��S�&&6�w&�V�C�4dTctc�&�&FW#�’�6�ƖB43C�43�&�&FW”�&F�W3�G��FF��s�G�����&v��#�#��#��7G��S�&f��B�6��S�G��6���#�3TcCc#��&v���f��B�vV�v�C�c#���G66R��FS�&WFG’WF�FR��b&�fVBv�F��6R���Vff�67�6��f�&�VB�v���&W&W6V�BF�R�W�BvV�W&F����7FW��t���&6VB�&W6�G�G&VF�V�B���vWfW”��Bv�����B&Rf��&�Rf�”6Ɩ�6�W6RV�F���FR##R�”##b�f�”F�V�G2����rG&VF�V�BFV6�6���2��r�6V�v�WF�FR�BF�’�WF�FR&V���F�RWf�FV�6R�&6VB�F���2������F�cࠣ�7G��S�’FW�B�Ɩv�&�v�C��&v�㣇�3’�#���&Vc�”7F�2″7G��S�&f��B�6��S�7��6���#�3Tccssc�FW�B�FV6�&F������R#�(i&6�F�6��FV�G3����������w��F����ࠣ���w��VF��r���ƃ”6�73�’w�&��6�ֆVF��r#�g&WVV�Fǒ6�VBVW7F���3���#�����w��VF��r��ࠣ���d��4T���DU#���6W’Bg&W6�&��F�d&��6��W&R��wWFV�&W&r��ࠣ���w��VF��r���ƃ”6�73�’w�&��6�ֆVF��r#�7V��’��B�W�F�Vv�3���#�����w��VF��r��ࠣ���w��F������7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�F��2’F�6�R�2F�7F���VBF�RWf�FV�6R��6V�v�WF�FR�BF�’�WF�FR7&�72�V6��6��Vff�67��6fWG��6�7B��B6Ɩ�6�Ɩ6F����F�R�W�f��F��w2&S���ࠣ�F�b7G��S�&&6�w&�V�C�4T$cTd3�&�&FW”��VgC�G�6�ƖB3DT�DS�FF��s�g�#���&v��#��#���&�&FW”�&F�W3�G�G�#��7G��S�&6���#�3DT�DS�f��B�6��S�’��f��B�vV�v�C�s��&v��g��FW�B�G&�6f�&ӧWW&66S��WGFW”�76��s��fV�#�W�f��F��r�Vff�67���W&&6������7G��S�&6���#�3c#�33�f��B�6��S�W��Ɩ�RֆV�v�C��s��&v��#�F�’�WF�FR&�GV6W2b�”W&6V�FvR���G2��&RvV�v�B��72F��6V�v�WF�FR���VB�F�ֆVBG&��2�#”Rg2�bR�5U$��T�B�R��F��2�26Ɩ�6�ǒ�V��vgVâf�”�rF�V�B�F�Bw2�FF�F����b�r���vWfW”�F��26��&�6��77V�W2&�F�G’Vw2&RB&�fVB�&W6�G�F�6W2�F�’�WF�FRR�r�6V�v�WF�FR”�B�r��6V�v�WF�FRw2F�6Rv2Ɩ֗FVB’�F��W&&�ƗG����BVff�67�6V�Ɩ�r������F�cࠣ�F�b7G��S�&&6�w&�V�C�4T$cTd3�&�&FW”��VgC�G�6�ƖB3DT�DS�FF��s�g�#���&v��#��#���&�&FW”�&F�W3�G�G�#��7G��S�&6���#�3DT�DS�f��B�6��S�’��f��B�vV�v�C�s��&v��g��FW�B�G&�6f�&ӧWW&66S��WGFW”�76��s��fV�#�W�f��F��r#�6&F��f67V�”FF7���WG’�����7G��S�&6���#�3c#�33�f��B�6��S�W��Ɩ�RֆV�v�C��s��&v��#�6V�v�WF�FR�2&�7V7F�fR6&F��f67V�”�WF6��RG&��FF�4T�T5B�6��v��r#R�4R&VGV7F���������F�&WF�2GV�G2v�F�W7F&Ɨ6�VB6&F��f67V�”F�6V6R�”��v�5b&�6��F�’�WF�FRw26&F��f67V�”�WF6��RG&���5U%52�5d�B��2��B�WBV&Ɨ6�VB�f�”F�V�G2v�F�5bF�6V6R�6V�v�WF�FR�27W’&V�FǒF�R��ǒG’Vrv�F��&B�WF6��RWf�FV�6R�b&V�Vf�B������F�cࠣ�F�b7G��S�&&6�w&�V�C�4T$cTd3�&�&FW”��VgC�G�6�ƖB3DT�DS�FF��s�g�#���&v��#��#���&�&FW”�&F�W3�G�G�#��7G��S�&6���#�3DT�DS�f��B�6��S�’��f��B�vV�v�C�s��&v��g��FW�B�G&�6f�&ӧWW&66S��WGFW”�76��s��fV�#�W�f��F��r3�vV�v�B&Vv���2&V�����7G��S�&6���#�3c#�33�f��B�6��S�W��Ɩ�RֆV�v�C��s��&v��#�&�F�G’Vw2&WV�&R��v���rG&VF�V�BF����F��vV�v�B��72�5DUC�’F�6��G2v��7F�VB6V�v�WF�FR&Vv��VB�SR�bvV�v�B��7Bv�F�����R�V”�5U$��T�B�C�’F�6��G2v��7F�VBF�’�WF�FR&Vv��VB�RRv�F�����R�V”�F�W6R6���V�G2&R6�&��2F�6V6R��vV�V�BF���2���B7W&W2������F�cࠣ�F�b7G��S�&&6�w&�V�C�4T$cTd3�&�&FW”��VgC�G�6�ƖB3DT�DS�FF��s�g�#���&v��#��#���&�&FW”�&F�W3�G�G�#��7G��S�&6���#�3DT�DS�f��B�6��S�’��f��B�vV�v�C�s��&v��g��FW�B�G&�6f�&ӧWW&66S��WGFW”�76��s��fV�#�W�f��F��rC�t�6�FRVffV7G2ff�”6V�v�WF�FS����7G��S�&6���#�3c#�33�f��B�6��S�W��Ɩ�RֆV�v�C��s��&v��#�F�’�WF�FR6W6W2��&R�W6V�32Rg2�#RR��Bf�֗F��r�rRg2�BR�F��6V�v�WF�FR�f�”F�V�G2v�F���”t�F��W&&�ƗG��”��F��W&�6RF��W6V�6V�v�WF�FR��&R&VfW&&�RFW7�FR��vW”vV�v�B��72������F�cࠣ�F�b7G��S�&&6�w&�V�C�4T$cTd3�&�&FW”��VgC�G�6�ƖB3DT�DS�FF��s�g�#���&v��#��#���&�&FW”�&F�W3�G�G�#��7G��S�&6���#�3DT�DS�f��B�6��S�’��f��B�vV�v�C�s��&v��g��FW�B�G&�6f�&ӧWW&66S��WGFW”�76��s��fV�#�W�f��F��rS�66W72�B6�7Bf’�����7G��S�&6���#�3c#�33�f��B�6��S�W��Ɩ�RֆV�v�C��s��&v��#�6V�v�WF�FR6���V�F��r�2��&Rv�FVǒf��&�R�B��vW”�6�7BF��F�’�WF�FR6���V�F��r�’&�B���RF�’�WF�FR��W&�V�B����fR��vW”6��76�7F�6RF��’&�B���R6V�v�WF�FR�vVv�g�����F�f�GV���7W&�6R�B66W726�GVF���2v���F�7FFRv��6�G’Vr�2&7F�6�ǒf��&�R������F�cࠣ�F�b7G��S�&&6�w&�V�C�4T$cTd3�&�&FW”��VgC�G�6�ƖB3DT�DS�FF��s�g�#���&v��#��#���&�&FW”�&F�W3�G�G�#��7G��S�&6���#�3DT�DS�f��B�6��S�’��f��B�vV�v�C�s��&v��g��FW�B�G&�6f�&ӧWW&66S��WGFW”�76��s��fV�#�W�f��F��rc�&�F�&R6fR��&�&�FVǒ6V�V7FVB�V�F���3����7G��S�&6���#�3c#�33�f��B�6��S�W��Ɩ�RֆV�v�C��s��&v��#�6W&��W2GfW’6RWfV�G2&R&&R��&�F��F�RF��&��B2�6V��v&��r�2&6VB��&�FV�BFFv�F���6��f�&�VB�V��6�v��gFW”b�֖�Ɩ��W��7W&W2�v��&�FFW”WfV�G2&R6�v��f�”6V�v�WF�FR’WBV�6�V”�bG’Vr�&V�FVB��V�F�W”G’Vr6W6W26�v�f�6�B���vǖ6V֖������F�&WF�2F�V�G2�&�F�6W6R&��’F�����V��72��72��#RR�bF�F’�֗F�vFVB’�&W6�7F�6RG&���r������F�cࠣ�7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#��#�#�f�”6Ɩ�6��2�BF�V�G2�f�vF��rF��2��G66R�F�R&V6���V�FF����27G&�v�Ff�’v&C��F6�F�RG’VrF�F�R��F�f�GV�w26�&7V�7F�6W2���6��v�R6���V�B�2V�fW’6�ǒ&&W7B�”&�F�v�&��&�F�&WV�&R��v���rG&VF�V�B�&�F�&R6fRf�”��7BF�V�G2�6���6R&6VB��5b&�6�f7F�’2�t�F��W&�6R�6�7B�66W72��B7V6�f�2&�fVB��F�6F���2�6�VW�Vf�”6V�v�WF�FR����ࠣ�7G��S�’FW�B�Ɩv�&�v�C��&v�㣇�3’�#���&Vc�”7F�2″7G��S�&f��B�6��S�7��6���#�3Tccssc�FW�B�FV6�&F������R#�(i&6�F�6��FV�G3����������w��F����ࠣ���w��F������F�b7G��S�&&6�w&�V�C�3cD3T3�&�&FW”�&F�W3����FF��s�3’�#����&v��C��FW�B�Ɩv�6V�FW”#��7G��S�&f��B�f֖Ǔ���R�7�7FV��&Ɩ��57�7FV�f��B�u6Vv�RT�r�&�&�F��6�2�6W&�c�f��B�6��S�#��f��B�vV�v�C�s�6���#�4dddddc��&v����Ɩ�RֆV�v�C��B#�F�R&W6V&6���fW2f7B�vR&VB���b�B6���RF��wB�fRF������7G��S�&f��B�f֖Ǔ���R�7�7FV��&Ɩ��57�7FV�f��B�u6Vv�RT�r�&�&�F��6�2�6W&�c�f��B�6��S�W��6���#�4#�C�c��&v��#��Ɩ�RֆV�v�C��b#��Wr6���V�B&Wf�Ww2�Wf�FV�6RWFFW2��B&�F�6���Ǘ6�2( B6�W&6VB�6�FVB��Bw&�GFV�f�”V��Rv��7GV�ǒ&VBF�R7GVF�W2������&Vc�&�GG3���WF�F��w2�7V’7F6��6���7V’67&�&R”F&vWC�%�&��”&V��&���V�W””7G��S�&F�7�����Ɩ�R�&��6��&6�w&�V�C�4dddddc�6���#�3cD3T3�f��B�6��S�W��f��B�vV�v�C�s�FF��s�’�3’��&�&FW”�&F�W3�g��FW�B�FV6�&F������S��WGFW”�76��s��7�#�7V’67&�&RF�WF�F��w2vVV�Ǔ�����F�c�����w��F����ࠣ���w��VF��r���ƃ”6�73�’w�&��6�ֆVF��r#�6V�V7FVB&VfW&V�6W2�B�W�7GVF�W3���#�����w��VF��r��ࠣ���w��F������7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�F��2’F�6�R&VƖW2��VW”�&Wf�WvVB&��’�ƗFW&GW&R�&V��r&RF�R�W�G&��2�Bf�V�FF����&VfW&V�6W26�FVBF�&�Vv��WC���ࠣ�V�7G��S�&�&v��#��FF��r��VgC�#��ƒ7G��S�&�&v��G��6���#�3c#�33�f��B�6��S�W��Ɩ�RֆV�v�C��s�Ɨ7B�7G��S����R#�v��F��r��WB���#��&Vc�&�GG3���V&�VB��6&������斂�v�b�33Scs�R”F&vWC�%�&��”&V��&���V�W””7G��S�&6���#�3DT�DR#�VffV7B�b6V�v�WF�FR��&�G�vV�v�B��GV�G2v�F��fW’vV�v�B�”�&W6�G��F�R5DU&�F�֗6VB�F�V&�R�&Ɩ�B��6V&��6��G&���VBG&���b��6R�vVV�ǒ7V&7WF�V�W26V�v�WF�FR����”�V����6WC��V���##�3�s��( 3����&Vc�&�GG3���V&�VB��6&������斂�v�b�33Scs�R”F&vWC�%�&��”&V��&���V�W””7G��S�&&6�w&�V�C�4TDcdd3�6���#�3cD3T3�f��B�vV�v�C�s�FF��s�’����&�&FW”�&F�W3�7��f��B�6��S���FW�B�FV6�&F������S��&v����VgC�g�#�V$�VC�����Ɠ��ƒ7G��S�&�&v��G��6���#�3c#�33�f��B�6��S�W��Ɩ�RֆV�v�C��s�Ɨ7B�7G��S����R#��7G&V&�fb�WB���#��&Vc�&�GG3���V&�VB��6&������斂�v�b�3ScS�#B”F&vWC�%�&��”&V��&���V�W””7G��S�&6���#�3DT�DR#�F�’�WF�FR��6RvVV�ǒf�”F�RG&VF�V�B�b�&W6�G�����”�V���V�v���VC��V���###�3�s�#^( 3#b���&Vc�&�GG3���V&�VB��6&������斂�v�b�3ScS�#B”F&vWC�%�&��”&V��&���V�W””7G��S�&&6�w&�V�C�4TDcdd3�6���#�3cD3T3�f��B�vV�v�C�s�FF��s�’����&�&FW”�&F�W3�7��f��B�6��S���FW�B�FV6�&F������S��&v����VgC�g�#�V$�VC�����Ɠ��ƒ7G��S�&�&v��G��6���#�3c#�33�f��B�6��S�W��Ɩ�RֆV�v�C��s�Ɨ7B�7G��S����R#�’V&���D�WB���#��&Vc�&�GG3���V&�VB��6&������斂�v�b�33sSSs#�”F&vWC�%�&��”&V��&���V�W””7G��S�&6���#�3DT�DR#�VffV7B�b6��F��VVBvVV�ǒ7V&7WF�V�W26V�v�WF�FRg2��6V&���vV�v�B��72���FV��6R��GV�G2v�F��&W6�G��F�R5DUB&�F�֗6VBG&������”�V�����V���##�3#S�CN( 3C#R���&Vc�&�GG3���V&�VB��6&������斂�v�b�33sSSs#�”F&vWC�%�&��”&V��&���V�W””7G��S�&&6�w&�V�C�4TDcdd3�6���#�3cD3T3�f��B�vV�v�C�s�FF��s�’����&�&FW”�&F�W3�7��f��B�6��S���FW�B�FV6�&F������S��&v����VgC�g�#�V$�VC�����Ɠ��ƒ7G��S�&�&v��G��6���#�3c#�33�f��B�6��S�W��Ɩ�RֆV�v�C��s�Ɨ7B�7G��S����R#�Ɩ�6�fb�WB���#��&Vc�&�GG3���V&�VB��6&������斂�v�b�3s�S#3”F&vWC�%�&��”&V��&���V�W””7G��S�&6���#�3DT�DR#�6V�v�WF�FR�B6&F��f67V�”�WF6��W2���&W6�G�v�F��WBF�&WFW3����”�V���V�v���VC��V���##3�3���###( 3##3″���&Vc�&�GG3���V&�VB��6&������斂�v�b�3s�S#3”F&vWC�%�&��”&V��&���V�W””7G��S�&&6�w&�V�C�4TDcdd3�6���#�3cD3T3�f��B�vV�v�C�s�FF��s�’����&�&FW”�&F�W3�7��f��B�6��S���FW�B�FV6�&F������S��&v����VgC�g�#�V$�VC�����Ɠ��ƒ7G��S�&�&v��G��6���#�3c#�33�f��B�6��S�W��Ɩ�RֆV�v�C��s�Ɨ7B�7G��S����R#�&���RĢWB���#��&Vc�&�GG3���V&�VB��6&������斂�v�b�3�ssb”F&vWC�%�&��”&V��&���V�W””7G��S�&6���#�3DT�DR#�6��F��VF����bF�’�WF�FRfW’7W2�6V&�f�”vV�v�B��vV�V�B��GV�G2v�F��&W6�G��F�R5U$��T�B�B&�F�֗�VBG&������”�V�����V���##C�33�SsN( 3S�R���&Vc�&�GG3���V&�VB��6&������斂�v�b�3�ssb”F&vWC�%�&��”&V��&���V�W””7G��S�&&6�w&�V�C�4TDcdd3�6���#�3cD3T3�f��B�vV�v�C�s�FF��s�’����&�&FW”�&F�W3�7��f��B�6��S���FW�B�FV6�&F������S��&v����VgC�g�#�V$�VC�����Ɠ��ƒ7G��S�&�&v��G��6���#�3c#�33�f��B�6��S�W��Ɩ�RֆV�v�C��s�Ɨ7B�7G��S����R#��&W2”WB���#��&Vc�&�GG3���V&�VB��6&������斂�v�b�3s��s��2″F&vWC�%�&��”&V��&���V�W””7G��S�&6���#�3DT�DR#�F�’�WF�FRfW’7W26V�v�WF�FRf�”vV�v�B��vV�V�B��GV�G2v�F��&W6�G��5U$��T�B�R��&�F�֗�VB�F�6R�W66�F�����VB�F�ֆVBG&������”�V�����V���##C�33���( 3�#����&Vc�&�GG3���V&�VB��6&������斂�v�b�3s��s��2″F&vWC�%�&��”&V��&���V�W””7G��S�&&6�w&�V�C�4TDcdd3�6���#�3cD3T3�f��B�vV�v�C�s�FF��s�’����&�&FW”�&F�W3�7��f��B�6��S���FW�B�FV6�&F������S��&v����VgC�g�#�V$�VC�����Ɠ��ƒ7G��S�&�&v��G��6���#�3c#�33�f��B�6��S�W��Ɩ�RֆV�v�C��s�Ɨ7B�7G��S����R#�&�6V�7F�6��WB���#��&Vc�&�GG3���V&�VB��6&������斂�v�b�33s#s3�”F&vWC�%�&��”&V��&���V�W””7G��S�&6���#�3DT�DR#�Vff�67��B6fWG��b6V�v�WF�FR”�B�rf�”vV�v�B��72���&W6RF�V�G2v�F�G�R”F�&WFW3�F�R5DU”&�F�֗�VBG&������”�V��F�&WFW2�&W2�WF#��V���##�#3�sS.( 3scB���&Vc�&�GG3���V&�VB��6&������斂�v�b�33s#s3�”F&vWC�%�&��”&V��&���V�W””7G��S�&&6�w&�V�C�4TDcdd3�6���#�3cD3T3�f��B�vV�v�C�s�FF��s�’����&�&FW”�&F�W3�7��f��B�6��S���FW�B�FV6�&F������S��&v����VgC�g�#�V$�VC�����Ɠ��ƒ7G��S�&�&v��G��6���#�3c#�33�f��B�6��S�W��Ɩ�RֆV�v�C��s�Ɨ7B�7G��S����R#�g&�2�WB���#��&Vc�&�GG3���V&�VB��6&������斂�v�b�3S�#3c””F&vWC�%�&��”&V��&���V�W””7G��S�&6���#�3DT�DR#�F�’�WF�FR�2GV�t��t��&V6WF�”v��7C��&�6���w���&�6����WF�72��B�6R&”&�F�֗�VBG&��&W7V�G2���&W6R�BF�&WF�2F�V�G3����”�V��F�&WFW26&S��V���###�CS�c( 3c����&Vc�&�GG3���V&�VB��6&������斂�v�b�3S�#3c””F&vWC�%�&��”&V��&���V�W””7G��S�&&6�w&�V�C�4TDcdd3�6���#�3cD3T3�f��B�vV�v�C�s�FF��s�’����&�&FW”�&F�W3�7��f��B�6��S���FW�B�FV6�&F������S��&v����VgC�g�#�V$�VC�����Ɠ��ƒ7G��S�&�&v��G��6���#�3c#�33�f��B�6��S�W��Ɩ�RֆV�v�C��s�Ɨ7B�7G��S����R#��6�:��RWB���#��&Vc�&�GG3���V&�VB��6&������斂�v�b�3#��c2″F&vWC�%�&��”&V��&���V�W””7G��S�&6���#�3DT�DR#�F��6�G��BF�R�WF&�Ɩ27��G&��S�F��vV�W6�2�G&VF�V�B��B7W’&V�B6��G&�fW’6�W3����”�V��WW”���FW&��VC��V���##��s�3N( 3C”���&Vc�&�GG3���V&�VB��6&������斂�v�b�3#��c2″F&vWC�%�&��”&V��&���V�W””7G��S�&&6�w&�V�C�4TDcdd3�6���#�3cD3T3�f��B�vV�v�C�s�FF��s�’����&�&FW”�&F�W3�7��f��B�6��S���FW�B�FV6�&F������S��&v����VgC�g�#�V$�VC�����Ɠ��ƒ7G��S�&�&v��G��6���#�3c#�33�f��B�6��S�W��Ɩ�RֆV�v�C��s�Ɨ7B�7G��S����R#�v����WB���#��&Vc�&�GG3���V&�VB��6&������斂�v�b�3SC�SCB”F&vWC�%�&��”&V��&���V�W””7G��S�&6���#�3DT�DR#�t��&V6WF�”v��7G2f�”&WfV�F����bG�R”F�&WFW2��GV�G2v�F��&W6�G��B&VF�&WFW3�7�7FV�F�2&Wf�Wr�B�WF��Ǘ6�3����”�V��F�&WFW2�&W2�WF#��V���##�##�3�^( 33�R���&Vc�&�GG3���V&�VB��6&������斂�v�b�3SC�SCB”F&vWC�%�&��”&V��&���V�W””7G��S�&&6�w&�V�C�4TDcdd3�6���#�3cD3T3�f��B�vV�v�C�s�FF��s�’����&�&FW”�&F�W3�7��f��B�6��S���FW�B�FV6�&F������S��&v����VgC�g�#�V$�VC�����Ɠ���V�ࠣ�7G��S�’FW�B�Ɩv�&�v�C��&v�㣇�3’�#���&Vc�”7F�2″7G��S�&f��B�6��S�7��6���#�3Tccssc�FW�B�FV6�&F������R#�(i&6�F�6��FV�G3����������w��F����ࠣ���w��VF��r���ƃ”6�73�’w�&��6�ֆVF��r#�gW’F�W”&VF��s�WF�F��w2wV�FW2�B&W6�W&6W3���#�����w��VF��r��ࠣ���w��F������7G��S�&6���#�3c#�33�f��B�6��S�w��Ɩ�RֆV�v�C�ヶ�&v��#�#�f�”FF�F����6��FW�B��t���&�6���w��&VwV�F�’�7FGW2��B6Ɩ�6�Ɩ6F����&VfW”F�F�Rf����v��rWF�F��w2wV�FW2�B’F�6�W3���ࠣ�V�7G��S�&�&v��#��FF��r��VgC�#G�#��ƒ7G��S�&�&v�����6���#�3c#�33�f��B�6��S�W��Ɩ�RֆV�v�C��r#���&Vc�”�WF�FW2�6V�v�WF�FR�”7G��S�&6���#�3DT�DR#�6��&V�V�6�fR6V�v�WF�FRwV�FS���( BFWF��VB����w&���6V�v�WF�FR�&�6���w��f�&�V�F���2�vVv�g����V��2�’�&V�7W2��W6R66W2��B���F�&��r���Ɠ��ƒ7G��S�&�&v�����6���#�3c#�33�f��B�6��S�W��Ɩ�RֆV�v�C��r#���&Vc�”�WF�FW2�F�’�WF�FR�”7G��S�&6���#�3DT�DR#�6��&V�V�6�fRF�’�WF�FRwV�FS���( BFWF��VB����w&���F�’�WF�FR�&�6���w��f�&�V�F���2���V�&���W&�V�B���V6��6���B6Ɩ�6�Ɩ6F������Ɠ��ƒ7G��S�&�&v�����6���#�3c#�33�f��B�6��S�W��Ɩ�RֆV�v�C��r#���&Vc�”�wV�FW2�v��66W72�”7G��S�&6���#�3DT�DR#�66W76��rt���VF�6F���3���7W&�6R�6�7B��B6���V�F��s���( B&7F�6�wV�FRF��’F���rt���Bt�”v��7G2���6�VF��r6���V�F��r�&�7�Wf�VF������Ɠ��ƒ7G��S�&�&v�����6���#�3c#�33�f��B�6��S�W��Ɩ�RֆV�v�C��r#���&Vc�”�wV�FW2�Wf�FV�6R��WfV�2�”7G��S�&6���#�3DT�DR#�V�FW’7F�F��rWf�FV�6R�WfV�2��6Ɩ�6�&W6V&6����( B��rF�Wf�VFR$5G2��’6W’fF����7GVF�W2��B7�7FV�F�2&Wf�Ww2���Ɠ��ƒ7G��S�&�&v�����6���#�3c#�33�f��B�6��S�W��Ɩ�RֆV�v�C��r#���&Vc�”�wV�FW2���b�ƗfW2�”7G��S�&6���#�3DT�DR#��&�6����WF�72�B��b�ƖfS�v�B��R�VVBF����s���( BFVWF�fR��F�G’Vr��b�ƗfW2�7FVG��7FFR67V�V�F�����B&7F�6�F�6��r��Ɩ6F���2���Ɠ��ƒ7G��S�&�&v�����6���#�3c#�33�f��B�6��S�W��Ɩ�RֆV�v�C��r#���&Vc�”�wV�FW2�&VwV�F�’��7FGW2�”7G��S�&6���#�3DT�DR#�dD&�f�7FGW2�bt���Bt�”v��7G3���( B7W’&V�B&VwV�F�’���G66R�B�VƖ�RWFFW2���Ɠ��ƒ7G��S�&�&v�����6���#�3c#�33�f��B�6��S�W��Ɩ�RֆV�v�C��r#���&Vc�”�wV�FW2�GfW’6R�&V7F���2�”7G��S�&6���#�3DT�DR#���v��rGfW’6R&V7F���2F�t��v��7G3���( B&7F�6�G&�V&�W6���F��rwV�FRf�”�W6V�f�֗F��r��B�F�W”6�����6�FRVffV7G2���Ɠ��ƒ7G��S�&�&v�����6���#�3c#�33�f��B�6��S�W��Ɩ�RֆV�v�C��r#���&Vc�”�wV�FW2����F�&��r�&�F�6���”7G��S�&6���#�3DT�DR#�6Ɩ�6����F�&��r&�F�6��f�”��7&WF��v��7G3���( Bv�B�’2�f�F�2��B76W76�V�G26��V�B&RG&6�VBGW&��rG&VF�V�B���Ɠ��ƒ7G��S�&�&v�����6���#�3c#�33�f��B�6��S�W��Ɩ�RֆV�v�C��r#���&Vc�”�WF�FW2�&WFG’WF�FR�”7G��S�&6���#�3DT�DR#�&WFG’WF�FS�F�RG&��Rv��7B��F�R��&�������( B&Wf�Wr�bt��”�t�”�v6u”G&��v��6��B�6R���G&��WFFW2���Ɠ��ƒ7G��S�&�&v�����6���#�3c#�33�f��B�6��S�W��Ɩ�RֆV�v�C��r#���&Vc�”�WF�FW2�Ɨ&v�WF�FR�”7G��S�&6���#�3DT�DR#�Ɨ&v�WF�FR�6�V�F�f�7F����7F���&V�Wf�C����( B6��&�6���b��FW”t��”����v��7G2F���FW&�GV��BG&��v��7G2���Ɠ���V�ࠣ�7G��S�’FW�B�Ɩv�&�v�C��&v�㣇�3’�#���&Vc�”7F�2″7G��S�&f��B�6��S�7��6���#�3Tccssc�FW�B�FV6�&F������R#�(i&6�F�6��FV�G3����������w��F����ࠣ���w��VF��r���ƃ”6�73�’w�&��6�ֆVF��r#�F�66���W#���#�����w��VF��r��ࠣ���w��F������F�b7G��S�&&6�w&�V�C�4T$cTd3�&�&FW”��VgC�G�6�ƖB3DT�DS�FF��s�g�#���&v��#���&�&FW”�&F�W3�G�G�#��7G��S�&6���#�3DT�DS�f��B�6��S�’��f��B�vV�v�C�s��&v��g��FW�B�G&�6f�&ӧWW&66S��WGFW”�76��s��fV�#�WF�F��w27F�F&BF�66���W#����7G��S�&6���#�3c#�33�f��B�6��S�W��Ɩ�RֆV�v�C��s��&v��#�F��2’F�6�R�2w&�GFV�f�”VGV6F����W’�6W2f�”&W6V&6�W’2��V�F�6&R&�f�FW’2��B��f�&�VBGV�G2��B�2��B�VF�6�Gf�6R�G&VF�V�B&V6���V�FF�����”7V’7F�GWFRf�”6��7V�FF���v�F�VƖf�VB�V�F�6&R&�fW76�����6V�v�WF�FR�BF�’�WF�FR&R&W67&�F����VF�6F���2F�B6��V�B��ǒ&RW6VBV�FW”�VF�6�7WW’f�6����F��26��&�6��&Vf�V7G2Wf�FV�6Rf��&�R2�b�&6�##b�B��&RWFFVB2�WrFFV�W&vW2�WF�F��w2��W2��&W&W6V�FF���2&Vv&F��rF�R67W&7��”6���WFV�W72�bF��2��f�&�F�����BW6W’277V�R��&W7��6�&�ƗG�f�”F�V�”W6R�bF��26��FV�B��v�26��7V�B��W”��6�6��&Vf�&R7F’F��r�7F���r��”6��v��r��VF�6F���������F�c�����w��F����ࠣ���w��F�����Ƈ”7G��S�&&�&FW#����S�&�&FW”�F��7�6�ƖB43C�43��&v��C����6�G���B”�ࠣ�F�b7G��S�&&6�w&�V�C�4c�c�d#�FF��s�3’�#����&v��3’��&�&FW”�F���6�ƖB4S�TTcR#��7G��S�&6���#�3c#�33�f��B�6��S�W��Ɩ�RֆV�v�C��s��&v��g�#��7G&��s�(i&Wf��W2wV�FS���7G&��s���&Vc�”�wV�FW2�v��66W72�”7G��S�&6���#�3DT�DR#�66W76��rt���VF�6F���3���7W&�6R�6�7B��B6���V�F��s�������7G��S�&6���#�3c#�33�f��B�6��S�W��Ɩ�RֆV�v�C��s��&v��#��7G&��s��W�B&W6�W&6S���7G&��s���&Vc�”�&W6V&6��vV�v�B���72��WF&�Ɩ2�WF�FW2�”7G��S�&6���#�3DT�DR#�vV�v�B��72b�WF&�Ɩ2�V�F��6���WFRWF�FR&W6V&6��V#��������F�c�����w��F����ࠣ�F&�R7G��S�’v�GF��S�&�&FW”�6���6S�6���6S��&v��#G�#��G#��F�7G��S�&&6�w&�V�B�6���#�3cD3T3�6���#�4dddddc�f��B�vV�v�C�s�FW�B�Ɩv��VgC�FF��s�’�g��&�&FW”�&�GF�ӣ’�6�ƖB3cD3T3�f��B�6��S�G�#��F�6F�����F���F�7G��S�&&6�w&�V�B�6���#�3cD3T3�6���#�4dddddc�f��B�vV�v�C�s�FW�B�Ɩv��VgC�FF��s�’�g��&�&FW”�&�GF�ӣ’�6�ƖB3cD3T3�f��B�6��S�G�#�6V�v�WF�FR�’&�B��W2���F���F�7G��S�&&6�w&�V�B�6���#�3cD3T3�6���#�4dddddc�f��B�vV�v�C�s�FW�B�Ɩv��VgC�FF��s�’�g��&�&FW”�&�GF�ӣ’�6�ƖB3cD3T3�f��B�6��S�G�#�F�’�WF�FR�’&�B��W2���F���F�7G��S�&&6�w&�V�B�6���#�3cD3T3�6���#�4dddddc�f��B�vV�v�C�s�FW�B�Ɩv��VgC�FF��s�’�g��&�&FW”�&�GF�ӣ’�6�ƖB3cD3T3�f��B�6��S�G�#�&�f�FFS��F����G#��G”7G��S�&&6�w&�V�B�6���#�4c�c�d”#��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#�G�R”F�&WFW3��FC��FB7G��S�’FF��s�’�g��&�&FW”�&�GF�ӣ�6�ƖB4S�TTcS�6���#�3c#�33�f��B�6��S�G��Ɩ�RֆV�v�C��c�fW’F�6��Ɩv�F�#���V��2��^-zW�1.0 mg/week); Rybelsus (oral formulation, 3–14 mg/day) Mounjaro (2.5–15 mg/week) Ozempic: 2017; Tirzepatide: 2022
Chronic Weight Management Wegovy (2.4 mg/week) Zepbound (10 mg or 15 mg/week) Wegovy: June 2021; Zepbound: Nov 2023
Type 2 Diabetes + Established CVD Ozempic (cardiovascular indication approved 2017) Mounjaro (CV indication pending SURPASS-CVOT results) Ozempic: 2017; Mounjaro: TBD
Obstructive Sleep Apnea Wegovy (approved June 2024, based on SLEEP trial) Not yet approved for this indication June 2024
Cardiovascular Risk Reduction (Non-Diabetic) Wegovy (approved Nov 2023 based on SELECT trial) Not yet approved for this indication (SURPASS-CVOT pending) Nov 2023

Notably, Novo Nordisk has sought and obtained specific cardiovascular and sleep apnea indications for semaglutide (Wegovy), while Eli Lilly has pursued a narrower approval strategy for tirzepatide (Zepbound), initially focusing on weight loss without seeking additional disease-specific indications. This reflects different corporate risk tolerances and timelines; Eli Lilly may apply for additional indications post-SURPASS-CVOT readout.

↑ Back to contents

Selected References and Key Studies

This article relies on peer-reviewed primary literature. Below are the key trials and foundational references cited throughout:

↑ Back to contents

Further Reading: Peptidings Guides and Resources

For additional context on GLP-1 pharmacology, regulatory status, and clinical application, refer to the following Peptidings guides and articles:

↑ Back to contents

Disclaimer

Peptidings Standard Disclaimer

This article is written for educational purposes for researchers, healthcare providers, and informed adults. It is not medical advice, a treatment recommendation, or a substitute for consultation with a qualified healthcare professional. Semaglutide and tirzepatide are prescription medications that should only be used under medical supervision. This comparison reflects evidence available as of March 2026 and may be updated as new data emerges. Peptidings makes no representations regarding the accuracy or completeness of this information, and users assume all responsibility for their use of this content. Always consult your physician before starting, stopping, or changing any medication.


Scroll to Top